dacarbazine and Metastase

dacarbazine has been researched along with Metastase in 329 studies

Research

Studies (329)

Timeframe	Studies, this research(%)	All Research%
pre-1990	124 (37.69)	18.7374
1990's	51 (15.50)	18.2507
2000's	77 (23.40)	29.6817
2010's	77 (23.40)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arance, A; Bastian, BC; Berking, C; Camargo, V; Carvajal, RD; Chen, Q; Daud, A; Dummer, R; Guo, J; Hauschild, A; Herchenhorn, D; Hertle, S; Hodi, FS; Markovic, SN; Nourry, C; Novick, S; Petrella, TM; Queirolo, P; Schadendorf, D; Sharfman, W; Testori, A	1
Barbaro, B; Barone, C; Basso, M; Calegari, MA; Camarda, F; Cassano, A; Cenci, T; de Pascalis, I; Gori, S; Inno, A; Larocca, LM; Martini, M; Monterisi, S; Orlandi, A; Santini, D; Tonini, G	1
Andersson, Y; Flatmark, K; Flem-Karlsen, K; Fodstad, Ø; Nunes-Xavier, CE; Tekle, C	1
Carilli, A; Pellini Ferreira, B; Vasquez, J	1
Kamimura, S; Kinoshita, M; Miyachi, M; Moritake, H; Sawa, D; Yamada, A	1
Anghel, RM; Haidar, A; Popescu, A	1
Cabezas, SS; Dos Santos, SN; Helal-Neto, E; Martínez-Máñez, R; Pinto, SR; Portilho, FL; Pozzo, L; Sancenón, F; Santos-Oliveira, R	1
Barker, P; Berking, C; Carvajal, RD; Chapman, PB; Chmielowski, B; Clemett, D; Cocquyt, V; Evans, TRJ; Frank, S; Gastaud, L; Ghiorghiu, D; Joshua, AM; Kapiteijn, E; Kilgour, E; Lai, Z; Linette, G; Lovick, S; Mariani, G; Nathan, P; Piperno-Neumann, S; Piulats, JM; Rodrigues, MJ; Schachter, J; Schwartz, GK; Shoushtari, AN; Spratt, S; Wolter, P	1
Altomonte, M; Bova, G; Calabrò, L; Camerini, R; Cisternino, F; Danielli, R; Di Giacomo, AM; Dragonetti, R; Giannarelli, D; Maio, M; Savelli, V	1
Ascierto, PA; Dréno, B; Flaherty, KT; Hauschild, A; Larkin, J; Lewis, KD; McArthur, GA; McKenna, E; Mun, Y; Ribas, A; Zhu, Q	1
Bartlett, NL; Fanale, MA; Fayad, LE; Gladstone, DE; Goy, A; Kasamon, YL; Lee, HJ; Oki, Y; Portlock, CS; Strati, P; Turturro, F; Wilson, WH; Younes, A	1
Li, D; Liu, Y; Qiao, L; Sun, M; Wang, L; Xu, S	1
Chi, Z; Cui, C; Gu, K; Guo, J; Kong, Y; Li, S; Lian, B; Lin, T; Mao, L; Qin, S; Ren, X; Sheng, X; Si, L; Song, X; Tao, M	1
Berge, EO; Birkeland, E; Busch, C; Geisler, J; Jönsson, G; Knappskog, S; Lillehaug, JR; Lønning, PE	1
Ejaz, S; Habra, MA; Henderson, SA; Shawa, H	1
Chi, Z; Cui, C; Guo, J; Kong, Y; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, B	1
Antonodimitrakis, P; Crona, J; Eriksson, B; Fanola, I; Granberg, D; Lindholm, DP; Öberg, K	1
Brennan, M; Garcon, MC; Kaley, K; Rodriguez, G; Rodriguez, T; Saif, MW	1
Borawska, MH; Markiewicz-Zukowska, R; Moskwa, J; Naliwajko, SK; Puscion-Jakubik, A; Socha, K; Soroczynska, J	1
Aandahl, G; Dalhaug, A; Haukland, E; Marienhagen, K; Nieder, C; Pawinski, A	1
Al Ghuzlan, A; Amar, L; Baudin, E; Bertherat, J; Borget, I; Caramella, C; Chougnet, C; Déandreis, D; Deschamps, F; Dumont, F; Favier, J; Gimenez-Roqueplo, AP; Hadoux, J; Leboulleux, S; Letouzé, E; Libé, R; Loriot, C; Schlumberger, M; Scoazec, JY; Young, J	1
Amonkar, MM; Chiarion-Sileni, V; Demidov, LV; Goodman, V; Grob, JJ; Grotzinger, K; Haney, P; Hauschild, A; Kämpgen, E; Karaszewska, B; Martin-Algarra, S; Mauch, C; Miller, WH; Millward, M; Mirakhur, B; Rutkowski, P; Swann, S	1
Hutchinson, L	1
Apetoh, L; Bel, B; Dalac, S; Ghiringhelli, F; Hervieu, A; Jeudy, G; Mignot, G; Vabres, P	1
Bouchaab, H; Bucher, M; Gaide, O; Homicsko, K; Letovanec, I; Michielin, O; Peters, S; Zimmerman, S	1
Brem, H; Cima, M; Grossman, R; Hwang, L; Langer, R; Masi, B; Patta, Y; Scott, A; Spencer, K; Tyler, B; Upadhyay, UM; Wicks, R	1
Finotello, R; Marconato, L; Stefanello, D; Zini, E	1
Armstrong, JL; Babatunde, F; Corazzari, M; Eleni Anagnostou, M; Hernandez-Tiedra, S; Hill, DS; Lopez-Valero, I; Lorente, M; Lovat, PE; McKee, CS; Redfern, CPF; Velasco, G	1
Amadon, JP; Hathaway, AR; Keith, BA	1
Gupta, K; Hardy, KM; Hendrix, MJ; Margaryan, NV; Murphy, GF; Scolyer, RA; Strizzi, L	1
Carvajal, RD; Mann, H; Nathan, PD; Schwartz, GK; Smith, I	1
Chyla, B; Daud, A; Falotico, N; Friedlander, P; Giranda, VL; Hamid, O; Jiang, F; Luo, Y; McArthur, GA; McKee, M; McKeegan, E; Middleton, MR; Mostafa, NM; Plummer, R; Qian, J; Zhu, M	1
Bíró, T; Buzás, K; Endrész, V; Gyukity-Sebestyén, E; Harmati, M; Katona, RL; Kemény, L; Marton, A; Nagy, K; Németh, IB; Oláh, J; Tubak, V; Vígh, L; Vizler, C; Zvara, Á	1
Arcella, A; Ascierto, PA; Cicala, D; De Divitiis, C; Grimaldi, AM; Iaffaioli, RV; Romano, GM; Simeone, E; Tafuto, S; Tatangelo, F; von Arx, C	1
Beyer, DT; Boudreaux, JP; Chauhan, A; Ramirez, RA; Wang, YZ; Woltering, EA	1
Danilov, AV; Friedberg, JW; Li, H; Noy, A; Press, OW; Reid, E; Shapira, I; Smith, SM; Swinnen, LJ	1
Averineni, RK; Guan, X; Sadhu, SS; Seefeldt, T; Wang, S; Yang, Y	1
Chen, H; Gill, H; Lubner, S; Matsumura, JB; Somnay, Y	1
Biteghe, FN; Davids, LM	1
Bakhshi, S; Bhethanabhotla, S; Chopra, A; Jain, S; Kapoor, G; Mahajan, A; Vishnubhatla, S	1
Barber, B; Kudlac, A; Ma, Q; Palmer, S; Quinn, C; Zhao, Z	1
Kerger, J; Kourie, HR; Simon, A	1
Barber, BL; Batty, N; Chen, YJ; Hines, DM; Ma, Q; Munakata, J; Zhao, Z	1
Asai, S; Katabami, T; Naruse, M; Tanaka, Y; Tsuiki, M	1
Bedikian, AY; Hwu, P; Hwu, WJ; Johnson, MM; Kim, K; McIntyre, S; Papadopoulos, N; Warneke, CL	1
Cheung, NK; Kramer, K; Kushner, BH; Laquaglia, MP; Modak, S	1
Bukowski, RM; Dreicer, R; Elson, P; Mekhail, T; Olencki, T; Roman, S; Tamaskar, I	1
Bar-Eli, M; Lev, DC; Melnikova, VO; Villares, GJ; Zigler, M	1
Agarwala, SS; Gooding, WE; Kirkwood, JM; Moschos, S; Tarhini, AA	1
Atkins, MB; Cohen, GI; Flaherty, LE; Hsu, J; Kirkwood, JM; Lee, S; Sondak, VK; Sosman, JA	1
Bar, J; Catane, R; Gutman, H; Kutchuk, I; Schachter, J; Shapira-Frummer, R; Sulkes, A; Yerushalmi, R	1
Ali-Osman, F; Augustine, CK; Friedman, HS; Nevins, JR; Potti, A; Tyler, DS; Yoo, JS; Yoshimoto, Y; Zipfel, PA	1
Bay, JO; Blay, JY; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Fargeot, P; Fayette, J; Guillemet, C; Mathoulin-Pelissier, S; Penel, N; Rios, M; Rolland, F; Thyss, A	1
Berger, W; Dehoux, M; DeNeve, N; Gaussin, JF; Kiss, R; Lefranc, F; Martin de Lassalle, E; Mathieu, V; Mijatovic, T; Pirker, C; Vernier, M	1
Casadevall, A; Dadachova, E; Guimaraes, AJ; Howell, RC; Jongco, AM; Koba, W; Nosanchuk, JD; Revskaya, E; Sellers, RS	1
Abdi, E; Beith, J; Corrie, PG; Kefford, RF; Kotasek, D; Margison, GP; Middleton, MR; Mortimer, P; Palmer, C; Ranson, M; Thomas, NP; Watson, AJ	1
Chang, JL; Farrell, K; Jones, A; Muggia, F; Oratz, R; Ott, PA; Pavlick, AC	1
Kimura, H; Kodama, H; Nomura, K; Obara, T; Okamoto, T; Shimizu, S; Takano, K	1
Bedikian, A; Gerber, DL; Homsi, J; Hwu, P; Hwu, WJ; Kim, KB; Papadopoulos, NE; Ring, S	1
Khuntia, D; Mehta, MP; Platta, CS; Suh, JH	1
Chaskis, C; Michotte, A; Neyns, B; Sadones, J; Veld, PI	1
Amatruda, T; Anderson, CM; Atkins, MB; Boasberg, P; Gonzalez, R; Hersh, EM; Lutzky, J; O'Day, SJ; Thompson, JA; Wang, HJ; Weber, JS	1
Clark, JI; Da Silva, DM; Flaherty, LE; Hutchins, LF; Kast, WM; Liu, PY; Moon, J; Sondak, VK; Sosman, JA; Thompson, JA	1
Bukofzer, G; Donawho, CK; Ellis, PA; Frost, DJ; Giranda, VL; Lasko, L; Liu, X; Montgomery, D; Niquette, A; Palma, JP; Penning, TD; Rodriguez, LE; Rosenberg, SH; Shi, Y; Wang, YC; Zhu, GD	1
Alvarado, GC; Bedikian, AY; Camacho, LH; Hwu, P; Kim, KB; McIntyre, S; Papadopoulos, NE; Yoon, C	1
Asselain, B; Barillot, E; Bessard, MA; Couturier, J; Dahmani, A; Decaudin, D; Desjardins, L; Donnadieu, MH; Gentien, D; Lantz, O; Laurent, C; Mariani, P; Némati, F; Péguillet, I; Piperno-Neumann, S; Plancher, C; Reyes, C; Robert, D; Roman-Roman, S; Sastre-Garau, X; Saule, S	1
Ali-Osman, F; Augustine, CK; Friedman, HS; Jung, SH; Olson, JA; Sohn, I; Tyler, DS; Yoo, JS; Yoshimoto, Y	1
Busch, C; Geisler, J; Lillehaug, JR; Lønning, PE	1
Dorr, R; Gonzalez, R; Grenier, K; Hersh, E; O'Day, S; Ribas, A; Samlowski, WE; Sato, T; Stephenson, J; Weber, JS	1
Lee, N; Setton, J	1
Chen, DT; Choi, J; Coppola, D; Fine, RL; Helm, J; Kvols, L; Nasir, A; Strosberg, JR	1
Agarwala, S; Bedikian, AY; Conry, R; DeConti, RC; Ernstoff, M; Kim, KB; Papadopoulos, N	1
Bassett, R; Bedikian, A; Hwu, P; Hwu, WJ; Kim, KB; Knight, RD; Papadopoulos, NE; Patnana, M	1
Bruneton, D; Cassier, PA; Chayvialle, JA; Hervieu, V; Lombard-Bohas, C; Pilleul, F; Scoazec, JY; Walter, T	1
Drabick, JJ; Fateh, S; Gingrich, R; Neves, RI; Schell, TD	1
Colucci, G; Cramarossa, A; Fistola, E; Giudice, G; Guida, M; Lubello, K; Porcelli, M	1
Bedikian, AY; Homsi, J; Hwu, P; Hwu, WJ; Johnson, MM; Kim, KB; McIntyre, S; Papadopoulos, NE; Rohlfs, M; Warneke, CL	1
Alamanda, V; Chellappan, S; Davis, R; Lawrence, N; Pernazza, D; Pireddu, R; Sebti, S; Singh, S	1
Bernardo, M; Chiang, J; Lonser, R; Lu, J; Martiniova, L; Pacak, K; Zhuang, Z	1
Kim, JH; Lee, HR; Lee, J; Lee, SI; Lim, DH; Park, KW; Yi, JH; Yi, SY	1
Araujo, DM; Benjamin, RS; Boonsirikamchai, P; Choi, H; Conrad, CA; Lazar, AJ; Ludwig, JA; Park, MS; Patel, SR; Trent, JC; Wang, WL; Wang, X	1
Chang, Z; Chen, D; Guo, J; Jia, D; Jin, C; Liu, J; Rao, W; Wang, C; Wang, S; Zhang, M	1
Andrieu-Abadie, N; Bedia, C; Casas, J; Fabriàs, G; Levade, T	1
Affolter, A; Ahmad, T; Chao, D; Chevreau, C; Corrie, P; Eisen, T; Gibbens, I; Gore, ME; Harries, M; James, MG; Jouary, T; Lorigan, P; Marais, R; Montegriffo, E; Nathan, PD; Negrier, S; Ottensmeier, C; Prendergast, S; Robert, C; Strauss, UP	1
Cella, D; Cormier, JN; Revicki, DA; Robinson, DW; Uhlar, CM; Zhao, N	1
de Braud, F; Eigentler, TK; Garbe, C; Giovannoni, L; González-Iglesias, R; Kaspar, M; Lovato, V; Menssen, HD; Neri, D; Pflugfelder, A; Romanini, A; Schwager, K; Spitaleri, G; Tasciotti, A; Trachsel, E; Weide, B	1
Algazi, AP; Andrews, SC; Daud, AI; DeConti, RC; Hwang, J; McCalmont, T; Messina, JL; Munster, PN; Sondak, VK; Urbas, P; Weber, JS	1
Chen, R; Devito, N; Pan, E; Yu, M	1
Queirolo, P; Spagnolo, F	1
Dreyer, C; Faivre, S; Raymond, E	1
Licitra, L; Locati, LD	1
Chang, J; Cheng, X; Escano, C; Gandhi, A; Kannan, R; Liebes, L; Madden, K; Mendoza, S; Muren, C; Ott, PA; Pavlick, AC; Shao, Y	1
de Boer, M; Lamers, MJ; van der Graaf, WT; van der Pluijm, RW; van Laarhoven, HW	1
Beumer, JH; Buch, SC; Christner, S; Egorin, MJ; Kirkwood, JM; Lin, Y; Moschos, S; Tarhini, AA; Tawbi, HA	1
Chapman, PB; Hwu, WJ; Livingston, PO; Panageas, KS; Quinn, C; Williams, L; Wolchok, JD	1
Dolan, ME; Park, DK; Ryan, CW; Stadler, WM; Vogelzang, NJ	1
Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C	1
Cappugi, P; Coronnello, M; Giannotti, B; Mini, E; Pimpinelli, N; Prignano, F	1
Ames, P; Boasberg, PD; Deck, R; Fournier, P; Gammon, G; Kim, H; Kristedja, TS; Martin, M; O'Day, SJ; Piro, L; Shinn, K; Wang, HJ	1
Christophers, E; Frick, S; Haacke, TC; Hauschild, A; Lischner, S; Rosien, F; Schäfer, F	1
Newton, HB	1
Aravantinos, G; Bafaloukos, D; Briasoulis, E; Fountzilas, G; Gogas, H; Kosmidis, P; Mylonakis, N; Samonis, G; Skarlos, DV; Stathopoulos, G	1
Eskelin, S; Hahka-Kemppinen, M; Kivelä, T; Muhonen, T; Nikkanen, V; Pyrhönen, S; Summanen, P; Tarkkanen, A	1
Bökönyi, G; Horváth, A; Kéri, G; Szende, B	1
Neville, F; Nystrom, ML; Oliver, RT; Shamash, J; Steele, JP	1
Gore, M; Hahka-Kemppinen, M; Hansson, J; Humblet, Y; Kivelä, T; Kloke, O; Kruit, WH; Kumpulainen, E; Parvinen, LM; Pyrhönen, S; Suciu, S; Vuoristo, MS	1
Arance, A; Ashcroft, L; Clamp, A; Danson, S; Hodgetts, J; Lomax, L; Lorigan, P; Middleton, MR; Ranson, M; Thatcher, N	1
Eisen, TG; Lens, MB	1
Zelger, B; Zelger, BG	1
Harkness, KA; Manford, MR	1
Eigentler, TK; Garbe, C	1
Amaducci, L; Biasco, G; Guida, M; Leoni, M; Michiara, M; Poletti, P; Ravaioli, A; Ridolfi, R; Romanini, A; Sileni, VC	1
Grange, JD; Kodjikian, L; Rivoire, M	1
Fernandez, CV; Rigby, H; Schmidt, MH; Yu, W	1
Kharoubi, S	1
Boddy, AV; Calvert, AH; Curtin, NJ; Harris, AL; Hickson, I; Jones, C; Margison, GP; McGown, G; McHugh, P; Middleton, MR; Newell, DR; Olsen, A; Plummer, ER; Thorncroft, M; Watson, AJ	1
Hahka-Kemppinen, M; Kellokumpu-Lehtinen, P; Korpela, M; Parvinen, LM; Pyrhönen, S; Seppä, H; Vuoristo, MS	1
Anderson, C; Baron, A; Gibbs, P; Gonzalez, R; Lewis, KD; O'Day, S; Richards, J; Russ, P; Weber, J; Zeng, C	1
Anderson, ME; Gebhardt, MC; Hornicek, FJ; Mankin, HJ; Raskin, KA	1
Eggermont, AM; Gore, M; Keilholz, U; Kleeberg, U; Kruit, W; Lehman, F; Lienard, D; Negrier, S; Patel, P; Proebstle, TM; Punt, CJ; Schadendorf, D; Schmittel, A; Suciu, S; Thomas, J; Velu, T	1
Denny, SR; Harvey, WB; Kashani-Sabet, M; Madland, MT; Minor, DR	1
Albritton, K; Goldsby, RE; McAllister, N; McCarville, MB; McNall-Knapp, RY; Rausen, AR; Wagner, LM	1
Abboud, MR; Al Kutoubi, AO; Alaraj, AM; Chamoun, RB; Haddad, GF	1
Becker, JC; Berger, T; Bröcker, EB; Burg, G; Edler, L; Enk, A; Grabbe, S; Jonuleit, H; Kamarashev, J; Kämpgen, E; Keikavoussi, P; Nestle, FO; Rittgen, W; Schadendorf, D; Schuler, G; Schuler-Thurner, B; Sucker, A; Tüttenberg, A; Ugurel, S; Zimpfer-Rechner, C	1
Bajetta, E; Bernengo, MG; Cascinelli, N; Daponte, A; Del Vecchio, M; Formisano, B; Fusi, A; Legha, SS; Nova, P; Queirolo, P; Sertoli, MR; Taveggia, P	1
Archimbaud, A; Basset-Seguin, N; Dubertret, L; Guitera, P; Kerob, D; Levy, A; Ollivaud, L	1
Bridgewater, J; Dawson, M; Donnelly, D; Gumbrell, L; Halbert, G; Jowle, D; Lee, SM; Margison, GP; McElhinney, RS; McGrath, H; McMurry, TB; Middleton, MR; Ranson, M; Waller, S	1
Bordeleau, L; Charpentier, D; Crump, M; Eisenhauer, E; Matthews, S; Trudeau, ME; Yelle, L	1
Holen, K	1
Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA	1
Amato, R; Doh, LS; Paulino, AC; Teh, BS	1
Hunter, K; Jones-Bolin, S; Klein-Szanto, A; Ruggeri, B; Zhao, H	1
Fountzilas, G; Frangia, K; Gogas, H; Mantzourani, M; Markopoulos, C; Middleton, M; Panagiotou, P; Papadopoulos, O; Pectasides, D; Polyzos, A; Stavrinidis, I; Tsoutsos, D; Vaiopoulos, G	1
Becker, JC; Beiteke, U; Bröcker, EB; Durani, B; Jünger, M; Junghans, V; Kortüm, AK; Mauch, C; Remling, R; Schadendorf, D; Schulze, HJ; Terheyden, P	1
Khan, MI; Kloecker, GH; Laber, DA; Salvador, C; Schonard, C; Taft, BS	1
Bertuzzi, A; Campagnoli, E; Parra, HJ; Quagliuolo, V; Santoro, A; Zucali, PA	1
Brandsma, D; van den Bent, MJ	1
Enk, A; Grabbe, S; Müller, ML; Nashan, D; Wustlich, S	1
Kleinberg, LR; Lin, SH	1
Acres, B; Bleuzen, P; Dummer, R; Lacoste, G; Limacher, JM; Rochlitz, C; Romero, P; Slos, P; Urosevic, M; Velu, T	1
Groves, MD; Katz, RL	1
Burger, PC; Cochran, EJ; Gujrati, M; Holland, EC; Huse, JT; Jost, SC; Miller, CR; Perry, A; Qian, J; Raghavan, R; Rosenblum, MK; Scheithauer, BW; Zambrano, SC	1
Komatsubara, H; Komori, T; Minamikawa, T; Ojima, Y; Shibuya, Y; Shigeta, T; Umeda, M; Yokoo, S	1
Berthold, F; Lampert, F; Niethammer, D; Treuner, J	1
Cheung, T; Cohen, SM; Holland, JF; Ohnuma, T	1
Allegra, JC; Blumenreich, MS; Gentile, PS; Kubota, TT; Richman, SP; Woodcock, TM	1
Foley, JF; Kessinger, A; Lemon, HM	1
Bernengo, MG; Doveil, GC; Lisa, F; Meregalli, M	1
Elliott, RS; Harrison, WH; Haskell, CM; Kaiser, LR; Morton, DL; Ramming, KR; Sarna, G; Silberman, AW; Storm, FK	1
Balch, CM; Bartolucci, AA; Murray, D; Presant, C	1
Santoro, A; Viviani, S	1
Baker, LH; Bhathena, DB; Cummings, G; McDonald, B; Samson, MK; Talley, RW	1
Ahmann, DL; Burgert, EO; Edmonson, JH; Fleming, TR; Ivins, JC; O'Connell, MJ; Sim, FH; Soule, EH	1
Cherubino, R; Giraldi, T; Mitri, E; Sava, G	1
Del Prete, SA; Forcier, RJ; LeMarbre, P; Maurer, LH; O'Donnell, J	1
Schlager, SI	1
Harada, M; Komi, N; Makinoya, T; Miyamoto, H; Miyoshi, Y; Tamura, T; Yamamoto, M	1
Bernengo, MG; Fra, P; Lisa, F; Meregalli, M; Zina, G	1
Hossfeld, DK; Lempidakis, S; Seeber, S	1
Brodsky, I; Bulova, SI; Conroy, JF; Kahn, SB; Pequignot, E; Roda, PI	1
Brach del Prever, A; Cordero di Montezemolo, L; Ghibaudo, P; Madon, E; Pastore, G	1
Moertel, CG; Rubin, J; van Hazel, GA	1
Karakousis, CP	2
Byrne, MJ; Reynolds, PM	1
Höffken, K; Schmidt, CG; Seeber, S; Siemers, E	1
Bolton, PM; Clunie, GJ; Dury, M; Furnival, CM; Gough, IR	1
Borisov, AI; Kogoniia, LM; Moroz, LV; Perevodchikova, NI; Platinskiĭ, LV	1
Bonmassar, E; Enrico, P; Goldin, A; Iorio, AM; Neri, M	1
Bodey, GP; Gutterman, JU; Hersh, EM; Robidoux, A	1
Falkson, G; Falkson, HC	1
Bartolucci, AA; Lowenbraun, S; Presant, CA; Smalley, RV	1
Bodey, GP; Burgess, MA; Gutterman, JU; Heilbrun, LK; Hersh, EM; Murphy, WK; Schwarz, MA; Stone, E; Turner-Chism, V	1
Baker, LH; Benjamin, RS; Bodey, GP; Bottomley, R; Burgess, MA; Rivkin, SE; Sinkovics, JG; Thigpen, T; Yap, BS	1
Bolling, R; Meyer-Hamme, S; Schauder, S	1
Dubois, JB; el Amrani, N; Mathieu-Daude, H; Melhouf, MM	1
Gröhn, P; Korpela, M; Kumpulainen, E; Vuoristo, M	1
Ishihara, K	2
Abdelmoumene, N; Couette, JE; Delisle, MJ; Schlumberger, M	1
Gröhn, P; Joensuu, H; Kellokumpu-Lehtinen, P; Korpela, M; Kumpulainen, E; Nevantaus, A; Tiusanen, K; Turunen, M; Vuoristo, MS	1
Brossart, P; Hunstein, W; Keilholz, U; Möhler, T; Scheibenbogen, C; Tilgen, W	1
Bleehen, NM; Brampton, M; Calvert, AH; Lee, SM; Newlands, ES; Rustin, GJ; Selby, P; Stevens, MF; Thatcher, N	1
Ameglio, F; Carpano, S; Cavaliere, R; Di Lauro, L; Frasca, AM; Lopez, M; Pignatti, F; Rosselli, M; Vici, P; Vitelli, G	1
Giraldi, T; Pacor, S; Perissin, L; Rapozzi, V; Zorzet, S	1
Berd, D; Mastrangelo, MJ	1
Bos, G; Brown, D; Fletcher, WS; Lebredo, L; Moseley, HS; Small, K; Woltering, EA	1
Ferrone, S; Imai, K; Kageshita, T; Kimura, T; Kuriya, N; Ono, T; Tsujisaki, M; Yoshii, A	1
Bukowski, RM; Eyre, HJ; Fleming, TR; Macdonald, JS; Peterson, RF; Rinehart, JJ; Rivkin, SE; Tangen, CM; Taylor, SA	1
Crowther, D; Lee, SM; Margison, GP; Thatcher, N	1
Bell, R; Catton, C; Cummings, B; Fornasier, V; Hao, Y; LeVay, J; O'Sullivan, B; Quirt, I; Warr, D	1
Bureau, B; Célérier, P; Dreno, B; Litoux, P	1
Falkson, CI	1
Aamdal, S; Boeryd, B; Carstensen, J; Jungnelius, U; Kågedal, B; Karlsson, M; Westberg, R; Wingren, S	1
Antoine, E; Auclerc, G; Benhammouda, A; Bizzari, JP; Borel, C; Paraiso, D; Petit, T; Rixe, O; Soubrane, C; Weil, M	1
Hahka-Kemppinen, M; Hernberg, M; Muhonen, T; Pyrhönen, S; Turunen, JP	1
Bonmassar, E; Leonetti, C; Lozupone, F; Tentori, L	1
Hahka-Kemppinen, M; Kangas, L; Muhonen, T; Pyrhönen, S	1
Lyng, H; Rofstad, EK	1
Bedikian, A; Buzaid, AC; Eton, O; Legha, SS; Papadopoulos, N; Plager, C; Ring, S	1
Kraybill, WG; Valle, AA	1
Phillips, KA; Toner, GC	1
Legha, SS	1
Fefer, A; Gold, PJ; Thompson, JA	1
Buzaid, AC; Poo, WJ; Schultz, MZ	1
Garbisa, S; Giraldi, T; Onisto, M; Perissin, L; Peron, A; Rapozzi, V; Zorzet, S	1
Rudolf, Z; Strojan, P	1
Bassères, N; Bizzari, JP; Bonerandi, JJ; Gérard, B; Grob, JJ; Richard, MA; Zarrour, H	1
Dreno, B; Legoux, B; Litoux, P; Mansat, E; Tessier, MH	1
Cohen, GL; Falkson, CI	1
Atzpodien, J; Buer, J; Franzke, A; Ganser, A; Hoffmann, R; Kirchner, H; Lassmann, S; Müller, I; Neuber, K; Oevermann, K; Probst, M	1
Bedikian, A; Benjamin, R; Buzaid, AC; Colome, M; Eton, O; Lee, JE; Lee, JJ; Legha, SS; Mansfield, P; Papadopoulos, N; Plager, C; Rice, J; Ring, S; Ross, M; Strom, E	1
Fuchs, T; Keilholz, U; Proebstle, TM; Scheibenbogen, C; Sterry, W	1
Einhorn, JH; Hwu, P; Marincola, FM; Rosenberg, SA; Schwartzentruber, DJ; Seipp, CA; Steinberg, SM; Topalian, SL; White, DE; Yang, JC	1
Gademann, G; Gollnick, H; Ulrich, J	1
Aamdal, S; Aaronson, N; Cebon, J; Coates, A; Dreno, B; Fierlbeck, G; Fraass, U; Gore, M; Grob, JJ; Henz, M; Kapp, A; Middleton, MR; Muller, M; Schadendorf, D; Seiter, S; Statkevich, P; Thatcher, N; Tilgen, W; Weiss, J	1
Garaci, E; Izzo, F; Pierimarchi, P; Ranuzzi, M; Rasi, G; Sinibaldi-Vallebona, P; Terzoli, E; Tuthill, C	1
Cognetti, F; Sega, FM; Serrone, L; Zeuli, M	1
Bocsi, J; Hidvégi, M; Lapis, K; Paku, S; Prónai, L; Rásó, E; Szende, B; Tömösközi-Farkas, R	1
Atkins, MB; Clancy, MA; Lawrence, DP; McDermott, DF; Mier, JW; Rubin, KM; van den Brink, MR	1
Eggermont, AM; Keilholz, U; Suciu, S	1
Kroon, BB; Nieweg, OE	1
Hwu, WJ	1
Becker, JC; Bröcker, EB; Fischer, WH; Lutz, WK; Wack, C	1
Güven, K; Kittler, H; Pehamberger, H; Wolff, K	1
Retsas, S	1
Baker, LH; Izbicki, RM; Ratanatharathorn, V; Samson, MK	1
Bellet, RE; Berd, D; Catalano, RB; Mastrangelo, MJ	2
Diem, E; Kokoschka, EM; Kühböck, J; Mach, K; Pehamberger, H; Pötzi, P	1
Dowd, PM; Everall, JD	1
Bürkle, K; Dimopoulos, J; Kühböck, J; Matras, H; Pötzi, P; Watzek, G	1
Boccardo, F; Musso, M; Porcile, G; Rosso, R; Santi, L	1
Banzet, P; Belaich, S; Chastang, C; Civatte, J; Cottenot, F; Israel, L; Jacquillat, C; Maral, J; Puissant, A	1
Westbury, G	1
Bolton, PM; Burnett, W; Clunie, GJ; Gough, IR	1
Klein, R; Krüger, GR; Sesterhenn, K	1
Einhorn, LH; Furnas, B	1
Kenis, Y; Pinedo, HM	1
Colsky, J; Costanza, ME; Cunningham, T; Nathanson, L; Regelson, W; Schoenfeld, D; Sedransk, N; Wolter, J	1
Golbey, RB; Wittes, JT; Wittes, RE	1
Cooper, MR; Muss, HB; Ramseur, WL; Rhyne, L; Richards, F; Spurr, CL; Stuart, JJ; White, DR	1
Baker, LH; Fraile, RJ; McDonald, B; Samson, MK; Talley, RW	1
Gallmeier, WM	1
Blume, MR; Chan, EY; Cohen, RJ; Friedman, MA; Gershow, J; Glassberg, AB; Kaufman, DA; Resser, KJ; Rosenbaum, EH; Williams, JE	1
Bedikian, AY; Benjamin, RS; Bodey, GP; Khankhanian, N; Valdivieso, M	1
Becker, B; Krupin, T; Singer, PR; Smith, ME	1
Höffken, K; Holfeld, H; Scherer, E; Schmidt, CG; Schmitt, G; Seeber, S; Siemers, E	1
Crowther, D; Gasiunas, N; Palmer, MK; Thatcher, N	1
Kenis, Y; Pinedo, HM; Staquet, M; Sylvester, R; Vendrik, CP	1
Ahmann, DL; Bisel, HF; Creagan, ET; Eagan, RT; Edmonson, JH; Hahn, RG	1
Benjamin, RS; Bodey, GP; Dosik, GM; Rodriguez, V	1
Carey, RW; Cosimi, AB; Kaufman, SD; Wood, WC	1
Currie, GA; Hedley, DW; McElwain, TJ	2
Wobbes, T	1
Giraldi, T; Houghton, PJ; Nisi, C; Taylor, DM	1
Gropp, C; Havemann, K; Schmidt, M; Sodomann, CP	1
Blumenschein, GR; Buzdar, AU; Krutchik, AN; Sinkovics, JG	1
Kokron, O; Pridun, N; Zischinsky, W	1
Deicher, H; Deinhardt, J; Deutschmann, KE; Peter, HH	1
Block, JB; Drakes, TP; Isacoff, W; Tabbarah, H	1
Comis, RL	1
Burgess, MA; Gottlieb, J; Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, R	1
Costanzi, JJ	1
Baker, LH; Balcerzak, S; Benjamin, RS; Blumenschein, GR; Bodey, GP; Bottomley, R; Burgess, MA; Coltman, C; Gottlieb, JA; Hoogstraten, B; Moon, TE; O'Bryan, RM; Quagliana, JM; Rivkin, SE; Rodriguez, V; Saiki, JH; Sinkovics, JG; Sullivan, P; Thigpen, T	1
Ahmann, DL; Bisel, HF; Eagan, RT; Edmonson, JH; Frytak, S; Hahn, RG; O'Connell, MJ	1
Bellett, RE; Bodurtha, AJ; Laucius, JF; Mastrangelo, MJ	1
Hersh, EM; Hewlett, JS; Luce, JK; McKelvey, EM; Moon, TE; Talley, RW	1
Cohen, SM; Greenspan, EM; Ratner, LH; Weiner, MJ	1
Bodey, GP; Lane, M; Luce, JK; McKelvey, EM; Moon, TE; Talley, RW; Vaitkevicius, VK	1
Bodurtha, A; Ghose, T; Guclu, A; MacDonald, AS; Norvell, ST; Tai, J	1
Goldman, RL; Heusinkveld, RS; Jones, SE	1
Aranha, GV; Grage, TB	1
Baker, LH; Benjamin, RS; Gottlieb, JA; Moon, TE; O'Bryan, RM	1
Cangir, A; Land, VJ; Morgan, SK; Nitschke, R; Pullen, J; Starling, SA	1
Finklestein, J; Kersey, J; Nesbit, ME; Simmons, R; Weiner, J	1
Beretta, G; Bonadonna, G; Cascinelli, N; Morabito, A; Veronesi, U	1
Carmo-Pereira, J; Oliveira Costa, F; Pimentel, P	1
Blumenshein, G; Burgess, MA; Gutterman, JU; Hersh, EM; Mavligit, GM; McBride, CM	1
Bleehen, NM	1
Gercovich, FG; Gottlieb, JA; Luna, MA	1
Falkson, G; Van Dyk, JJ	1
Luce, JK	1
Barto, DA; Hendrickson, C; Sams, BJ; Susens, GP	1
Kleeberg, UR; Schreml, W	1
Binder, M; Dorffner, R; Glebowski, E; Pehamberger, H; Winkler, A; Wolff, K	1
Bella, M; Boni, C; Buzzi, F; Calabresi, F; Canaletti, R; Ceci, G; Cocconi, G; Corgna, E; Costa, P; Tonato, M	1
Guerry, D; Schuchter, LM	1
Bliss, JM; Gore, ME; Lakhani, S; McElwain, TJ; Perren, TJ; Selby, P	1
Abbott, BJ; Boyd, MR; Dykes, DJ; Fodstad, O; Griswold, DP; Harrison, SD; Mayo, JG; Plowman, J; Shoemaker, RH	1
Dietel, M; Hossfeld, DK; Schwarz, R; Weh, HJ; Wingberg, D; Zornig, C; Zügel, M	1
Ernstoff, MS; Kirkwood, JM; Luger, SM; Vlock, DR	1
Engelhardt, D; Jacob, K; Mann, K; Markl, A; Saller, B; Zwiebel, FM	1
Bradley, EC; Chabot, GG; Flaherty, LE; Gualdoni, SM; Heilbrun, LK; Martino, S; Redman, BG; Valdivieso, M	1
Hansson, J; Jungnelius, U; Ringborg, U; Strander, H	1
Balch, CM	2
Biran, S; Sulkes, A; Yahalom, J	1
Logothetis, CJ; Ro, JY; Samuels, ML; Sella, A; Swanson, DA	1
Foltz, AT; York, RM	1
English, JS; Lever, RS; MacKie, RM; Young, DW	1
Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D	1
Hafström, L; Hansson, J; Ringborg, U; Rudenstam, CM; Stenstam, B; Strander, H	1
Schoen, HD; Wendt, T	1
Benson, JB; Ferrara, JJ; Fucci, JC	1
Buck, M; Kvols, LK	1
Giraldi, T; Perissin, L; Sava, G; Zorzet, S	1
Baker, LH; Balcerzak, SP; Fine, G; Frank, J; Rivkin, S; Saiki, J; Stephens, RL; Stuckey, WJ; Ward, JH	1
Kremer, G; Sauer, H; Wilmanns, W	1
Czarnetzki, B; Kleeberg, UR; Mulder, J; Rozencweig, M; Rumke, P; Suciu, S; Thomas, D; Truchetet, F; Verschraegen, CF	1
Benjamin, RS; Bodey, GP; Burgess, AM; Legha, SS; Polyzos, A	1
Amato, DA; Borden, EC; Carbone, PP; Creech, RH; Enterline, HT; Lerner, HJ; Rosenbaum, C; Shiraki, MJ	1
Blum, R; Green, M; Muggia, FM; Oratz, R; Speyer, JL; Wernz, JC	1
Giraldi, T; Grill, V; Mallardi, F; Perissin, L; Zorzet, S	1
Anderson, H; Craig, P; Davenport, P; James, R; Thatcher, N	1
Falkson, G; Sarli, R; Vorobiof, DA	1
Garbe, C; Orfanos, CE; Stadler, R	1
Craig, P; Mene, A; Orton, C; Smith, D; Thatcher, N; Wagstaff, J	1
Abdi, EA; McPherson, TA; Tan, YH	1
Nosek, H; Pawlicki, M; Skołyszewski, J; Stryjewska, B	1
Brunet, R; Bui, NB; Chauvergne, J; Coindre, JM; Durand, M; Hocke, C	1
Lele, SB; Patsner, B; Piver, MS	1
Case, LD; Cooper, MR; Jackson, DV; Muss, HB; Richards, F; Spurr, CL; Sterchi, JM; Stuart, JJ; Wells, HB; White, DR	1
Dunleavy, S; Golomb, F; Harris, M; Hochster, H; Levin, M; Muggia, F; Roses, D; Speyer, J	1
Etcubanas, E; Horowitz, M; Vogel, R	1

Reviews

30 review(s) available for dacarbazine and Metastase

Article	Year
Treating malignant melanoma when a rare BRAF V600M mutation is present: case report and literature review. Romanian journal of internal medicine = Revue roumaine de medecine interne, 2018, Jun-01, Volume: 56, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Humans; Interferons; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Metastasis; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Vemurafenib	2018
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison. Advances in therapy, 2017, Volume: 34, Issue:2 Topics: Antineoplastic Agents; Cancer Vaccines; Dacarbazine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Melanoma; Neoplasm Metastasis; Treatment Outcome	2017
Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review. Chinese journal of cancer, 2017, Jan-13, Volume: 36, Issue:1 Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Metastasis; Proto-Oncogene Mas; Proto-Oncogene Proteins B-raf; Treatment Outcome	2017
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. Journal of immunotoxicology, 2008, Volume: 5, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Databases, Factual; Disease-Free Survival; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms; Survival Rate; Uveal Neoplasms; Vinblastine	2008
Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. American journal of clinical dermatology, 2008, Volume: 9, Issue:5 Topics: Antibodies, Monoclonal; Antineoplastic Agents; CD146 Antigen; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Humans; Immunotherapy; Interleukin-8; Melanoma; Neoplasm Metastasis; Skin Neoplasms	2008
Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. American journal of clinical oncology, 2010, Volume: 33, Issue:4 Topics: Blood-Brain Barrier; Brain; Brain Neoplasms; Cognition; Dacarbazine; Humans; Neoplasm Metastasis; Prognosis; Radiation-Sensitizing Agents; Radiosurgery; Survival Rate; Temozolomide; Time Factors	2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival? Melanoma research, 2011, Volume: 21, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferon-alpha; Interleukin-2; Logistic Models; Male; Melanoma; Neoplasm Metastasis; Paclitaxel; Proportional Hazards Models; Remission Induction; Sex Factors; Skin Neoplasms; Treatment Outcome; Vinblastine	2011
Upcoming strategies for the treatment of metastatic melanoma. Archives of dermatological research, 2012, Volume: 304, Issue:3 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dacarbazine; Humans; Indoles; Ipilimumab; MAP Kinase Kinase Kinases; Melanoma; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-kit; Skin Neoplasms; Sulfonamides; Vemurafenib	2012
Chemotherapy for the treatment of metastatic brain tumors. Expert review of anticancer therapy, 2002, Volume: 2, Issue:5 Topics: Antineoplastic Agents; Brain Neoplasms; Carboplatin; Clinical Trials as Topic; Dacarbazine; Humans; Neoplasm Metastasis; Temozolomide	2002
Systemic chemotherapy in the treatment of malignant melanoma. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Humans; Lomustine; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Tamoxifen; Treatment Outcome; Vincristine	2003
[Therapy of malignant melanoma at the stage of distant metastasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine	2004
Therapeutic and palliative options for diffuse neuroendocrine metastatic disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:3 Topics: Antineoplastic Agents; Dacarbazine; Humans; Immunologic Factors; Neoplasm Metastasis; Neuroendocrine Tumors; Nitrosourea Compounds; Palliative Care; Pancreatic Neoplasms; Somatostatin	2006
Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncology (Williston Park, N.Y.), 2006, Volume: 20, Issue:6 Topics: Brain Neoplasms; Carcinoma, Renal Cell; Dacarbazine; Humans; Kidney Neoplasms; Metalloporphyrins; Neoplasm Metastasis; Radiation Oncology; Radiation-Sensitizing Agents; Radiosurgery; Temozolomide	2006
Molecular targeted therapies and chemotherapy in malignant gliomas. Current opinion in oncology, 2007, Volume: 19, Issue:6 Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Disease-Free Survival; Glioma; Humans; Medical Oncology; Models, Biological; Neoplasm Metastasis; Oligodendroglioma; Signal Transduction; Temozolomide; Treatment Outcome	2007
Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:10 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Dacarbazine; Evidence-Based Medicine; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Melanoma; Neoplasm Metastasis; Prognosis	2007
Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. Expert review of anticancer therapy, 2008, Volume: 8, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Dacarbazine; Delayed-Action Preparations; Glioma; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Temozolomide	2008
[Chemotherapy of malignant melanoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Humans; Immunotherapy, Adoptive; Melanoma; Neoplasm Metastasis; Nimustine; Peplomycin; Vincristine	1995
Xenograft model systems for human melanoma. Molecular medicine today, 1996, Volume: 2, Issue:9 Topics: Animals; Cell Transplantation; Dacarbazine; Humans; Immunohistochemistry; Melanoma; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasms, Experimental; Tumor Cells, Cultured	1996
Management of soft tissue sarcomas of the extremity in adults. Journal of surgical oncology, 1996, Volume: 63, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Extremities; Humans; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Vincristine; Wound Healing	1996
Chemotherapy for soft tissue sarcomas. Indications and advances. Acta orthopaedica Scandinavica. Supplementum, 1997, Volume: 273 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Humans; Neoplasm Metastasis; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Vincristine	1997
Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy. Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 4 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Humans; Interferon-alpha; Interleukin-2; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Vincristine	1997
Current treatment options for malignant melanoma. Drugs, 1998, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cancer Vaccines; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Genetic Therapy; Humans; Interleukin-2; Melanoma; Neoplasm Metastasis	1998
Management of malignant melanoma. Annales chirurgiae et gynaecologiae, 2000, Volume: 89, Issue:3 Topics: Adult; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Case-Control Studies; Dacarbazine; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Life Expectancy; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Risk Factors; Skin; Skin Neoplasms; Sunscreening Agents; Survival Analysis; Time Factors	2000
New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide. Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:12 Suppl 1 Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Temozolomide; Thalidomide	2000
Adjuvant therapy of malignant melanoma: is there a choice? Critical reviews in oncology/hematology, 2001, Volume: 40, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Follow-Up Studies; Humans; Interferons; Lymphatic Metastasis; Melanoma; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Staging; Premedication; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vindesine	2001
Chemotherapy of advanced soft-tissue sarcomas in adults. Cancer treatment reviews, 1977, Volume: 4, Issue:2 Topics: Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Methotrexate; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine	1977
[Chemotherapy of malignant melanomas]. Haematology and blood transfusion, 1978, Volume: 21 Topics: Adjuvants, Immunologic; Antineoplastic Agents; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Immunotherapy; Lymphatic Metastasis; Male; Melanoma; Mycobacterium bovis; Neoplasm Metastasis; Nitrosourea Compounds; Prognosis; Vincristine	1978
DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer treatment reports, 1976, Volume: 60, Issue:2 Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Mice; Neoplasm Metastasis; Nitrosourea Compounds; Remission, Spontaneous; Triazenes	1976
[Diagnosis and prognosis of malignant melanoma]. Deutsche medizinische Wochenschrift (1946), 1985, Nov-15, Volume: 110, Issue:46 Topics: Alkaline Phosphatase; Dacarbazine; Female; Humans; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Palliative Care; Palpation; Prognosis; Radionuclide Imaging; Skin; Skin Neoplasms	1985
Chemotherapy of metastatic carcinoid and islet cell tumors. A review. The American journal of medicine, 1987, May-29, Volume: 82, Issue:5B Topics: Adenoma, Islet Cell; Antineoplastic Agents; Carcinoid Tumor; Dacarbazine; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Pancreatic Neoplasms; Streptozocin	1987

Trials

109 trial(s) available for dacarbazine and Metastase

Article	Year
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Jun-01, Volume: 28, Issue:6 Topics: Aged; Antineoplastic Agents; Dacarbazine; Exons; Female; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Proto-Oncogene Proteins c-kit; Pyrimidines; Survival Analysis	2017
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation. British journal of cancer, 2017, May-09, Volume: 116, Issue:10 Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; GTP Phosphohydrolases; Humans; Membrane Proteins; Middle Aged; Mutation; Nausea; Neoplasm Metastasis; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Retreatment; Survival Rate; Temozolomide; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vomiting	2017
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 04-20, Volume: 36, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; Double-Blind Method; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Placebos; Progression-Free Survival; Uveal Neoplasms	2018
ABVD plus rituximab Haematologica, 2019, Volume: 104, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Metastasis; Neoplasm Staging; Rituximab; Treatment Outcome; Vinblastine	2019
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma. Molecular therapy : the journal of the American Society of Gene Therapy, 2013, Volume: 21, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dacarbazine; Disease-Free Survival; Double-Blind Method; Endostatins; Female; Humans; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Young Adult	2013
Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Aug-15, Volume: 19, Issue:16 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dacarbazine; Female; Genotype; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Mucous Membrane; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Temozolomide; Treatment Outcome; Young Adult	2013
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:7 Topics: Antineoplastic Agents; Dacarbazine; Humans; Imidazoles; Melanoma; Neoplasm Metastasis; Oximes; Quality of Life	2014
Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT). BMC cancer, 2015, Jun-10, Volume: 15 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Uveal Neoplasms	2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Benzimidazoles; Brain Neoplasms; Dacarbazine; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Poly(ADP-ribose) Polymerase Inhibitors; Prognosis; Survival Rate; Temozolomide; Young Adult	2015
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leukemia & lymphoma, 2017, Volume: 58, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Vinblastine	2017
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease. Investigational new drugs, 2008, Volume: 26, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasms; Survival Rate; Taxoids; Temozolomide	2008
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma. Cancer, 2008, Oct-01, Volume: 113, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Temozolomide	2008
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordin Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Dec-10, Volume: 26, Issue:35 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Time Factors; Treatment Outcome; United States; Vincristine; Young Adult	2008
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma. Investigational new drugs, 2009, Volume: 27, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Sarcoma; Survival Rate; Treatment Outcome; Young Adult	2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma. British journal of cancer, 2009, Apr-21, Volume: 100, Issue:8 Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Child; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Patient Selection; Purines; Skin Neoplasms; Temozolomide; Thrombocytopenia	2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. Chemotherapy, 2009, Volume: 55, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Thalidomide	2009
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma. American journal of clinical oncology, 2009, Volume: 32, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Paclitaxel; Skin Neoplasms; Survival Analysis; Treatment Outcome	2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-20, Volume: 27, Issue:36 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Skin Neoplasms; Survival Analysis; Vinblastine; Young Adult	2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer, 2010, Jan-15, Volume: 116, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Temozolomide; Thalidomide	2010
A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma. Cancer, 2010, Aug-01, Volume: 116, Issue:15 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Hexanones; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	2010
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Paclitaxel	2011
Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy. Melanoma research, 2010, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Lenalidomide; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Survival Rate; Thalidomide	2010
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies. British journal of cancer, 2011, Jul-26, Volume: 105, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Pyridines; Skin Neoplasms; Sorafenib	2011
Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study. Melanoma research, 2012, Volume: 22, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pain; Pain Measurement; Psychometrics; Quality of Life; Surveys and Questionnaires	2012
A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fever; Humans; Male; Melanoma; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Recombinant Fusion Proteins; Survival Analysis; Survival Rate; Treatment Outcome	2011
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. British journal of cancer, 2012, Jan-03, Volume: 106, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dasatinib; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pyrimidines; src-Family Kinases; Survival Analysis; Thiazoles; Treatment Outcome	2012
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1 Topics: Adult; Aged; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Dacarbazine; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Oligonucleotides, Antisense; Paclitaxel; Skin Neoplasms; Temozolomide; Thionucleotides; Treatment Outcome	2013
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Dacarbazine; Decitabine; Disease-Free Survival; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Skin Neoplasms; Temozolomide	2013
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2 Topics: Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma, Renal Cell; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Kidney Neoplasms; Life Tables; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Salvage Therapy; Survival Analysis; Temozolomide; Treatment Failure	2002
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Drug Eruptions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hyperthyroidism; Immunologic Factors; Interleukin-2; Life Tables; Melanoma; Neoplasm Metastasis; Prospective Studies; Remission Induction; Survival Analysis; Tamoxifen; Thrombocytopenia; Treatment Outcome; Vinblastine	2002
Docetaxel in combination with dacarbazine in patients with advanced melanoma. Oncology, 2002, Volume: 63, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Docetaxel; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Paclitaxel; Remission Induction; Skin Neoplasms; Survival Analysis; Taxoids	2002
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Cancer, 2002, Dec-01, Volume: 95, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Female; Humans; Injections, Intravenous; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Uveal Neoplasms; Vincristine	2002
Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial. Melanoma research, 2003, Volume: 13, Issue:2 Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lomustine; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Tamoxifen; Time Factors; Treatment Outcome; Vinblastine	2003
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Feasibility Studies; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms; Vincristine	2003
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-01, Volume: 21, Issue:13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Survival; Temozolomide; Thalidomide	2003
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup. Melanoma research, 2004, Volume: 14, Issue:4 Topics: Adult; Aged; Dacarbazine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon-alpha; Italy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Survival Rate; Temozolomide; Treatment Outcome	2004
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-01, Volume: 11, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Comet Assay; Dacarbazine; DNA Damage; DNA Methylation; DNA Repair; DNA, Neoplasm; Female; Headache; Humans; Lymphocytes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Poly(ADP-ribose) Polymerases; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome	2005
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma. Melanoma research, 2005, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon Type I; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine	2005
A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF. Cancer investigation, 2005, Volume: 23, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Eye Neoplasms; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-2; Melanoma; Middle Aged; Neoplasm Metastasis; Reproducibility of Results; Skin Neoplasms; Survival Analysis; Temozolomide	2005
Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-20, Volume: 23, Issue:27 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Europe; Female; Follow-Up Studies; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Probability; Proportional Hazards Models; Recombinant Proteins; Reference Values; Skin Neoplasms; Survival Rate; Treatment Outcome	2005
Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. Acta neurochirurgica, 2006, Volume: 148, Issue:2 Topics: Adolescent; Antineoplastic Agents, Alkylating; Astrocytoma; Child; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neurosurgical Procedures; Radiotherapy; Spinal Cord; Spinal Cord Neoplasms; Temozolomide; Treatment Outcome	2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4 Topics: Cancer Vaccines; Dacarbazine; Dendritic Cells; Humans; Melanoma; Neoplasm Metastasis; Peptides	2006
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Vinblastine	2006
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5 Topics: Adenosine Triphosphatases; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Safety; Temozolomide	2006
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Patient Selection; Temozolomide; Treatment Outcome	2006
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. Melanoma research, 2006, Volume: 16, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Thrombocytopenia; Uveal Neoplasms	2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:12 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pyrazoles; Skin Neoplasms; Sulfonamides; Survival Analysis; Temozolomide	2006
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer. Cancer biology & therapy, 2007, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Temozolomide; Thalidomide; Treatment Outcome	2007
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma. Molecular therapy : the journal of the American Society of Gene Therapy, 2008, Volume: 16, Issue:5 Topics: Adenoviridae; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dacarbazine; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis	2008
Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases. Canadian Medical Association journal, 1983, Apr-15, Volume: 128, Issue:8 Topics: Antineoplastic Agents; BCG Vaccine; Clinical Trials as Topic; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Random Allocation; Skin Neoplasms	1983
Clinical thermochemotherapy. A controlled trial in advanced cancer patients. Cancer, 1984, Feb-15, Volume: 53, Issue:4 Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Female; Fluorouracil; Follow-Up Studies; Hot Temperature; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Metastasis; Neoplasms	1984
Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma. Surgery, 1984, Volume: 95, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Propionibacterium acnes; Prospective Studies; Random Allocation; Skin Neoplasms	1984
[Results of chemotherapy of soft tissue sarcoma in adults]. La Radiologia medica, 1984, Volume: 70, Issue:11 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Vincristine	1984
Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. Cancer treatment reports, 1982, Volume: 66, Issue:2 Topics: Adolescent; Adult; Bone Marrow; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Digestive System; Drug Therapy, Combination; Female; Humans; Kidney; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Streptozocin	1982
Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Sarcoma; Vincristine	1984
A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results. Cancer, 1980, Aug-01, Volume: 46, Issue:3 Topics: Bacterial Vaccines; Clinical Trials as Topic; Dacarbazine; Female; Humans; Immunotherapy; Injections, Intramuscular; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Pancytopenia; Prognosis; Propionibacterium acnes; Skin Neoplasms; Vomiting	1980
[Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma]. Voprosy onkologii, 1981, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Methylnitrosourea; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Skin Neoplasms; Time Factors; Vincristine	1981
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma. Cancer, 1982, Jun-01, Volume: 49, Issue:11 Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Propionibacterium acnes	1982
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine. Cancer, 1981, Feb-01, Volume: 47, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine	1981
Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Treatment Outcome; Vincristine	1994
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC). British journal of cancer, 1995, Volume: 71, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Radiotherapy, Adjuvant; Streptozocin; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome	1995
Intermittent interferon and polychemotherapy in metastatic melanoma. Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Vincristine	1995
Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1995, Volume: 139 Topics: Cisplatin; Combined Modality Therapy; Dacarbazine; Humans; Immunologic Factors; Interferon-alpha; Interleukin-2; Melanoma; Neoplasm Metastasis; Pilot Projects; Remission Induction; Salvage Therapy; Skin Neoplasms; Treatment Outcome	1995
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Survival Rate; Temozolomide; Thrombocytopenia; United Kingdom	1995
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:8 Topics: Adult; Aged; CD4 Antigens; CD8 Antigens; Combined Modality Therapy; Dacarbazine; Female; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Skin Neoplasms; Thymalfasin; Thymosin	1994
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study. Cancer, 1994, Mar-01, Volume: 73, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis	1994
Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. British journal of cancer, 1994, Volume: 69, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Humans; Kinetics; Leukocytes, Mononuclear; Male; Melanoma; Methyltransferases; Middle Aged; Neoplasm Metastasis; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Time Factors	1994
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma. Medical oncology (Northwood, London, England), 1995, Volume: 12, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recombinant Proteins; Remission Induction; Treatment Outcome	1995
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. International journal of cancer, 1996, Jan-03, Volume: 65, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; DNA, Neoplasm; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Ploidies; Regression Analysis; S Phase; Survival Analysis; Vindesine	1996
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients. Melanoma research, 1995, Volume: 5, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine	1995
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Survival Rate; Treatment Outcome; Vinblastine	1996
Outpatient chemoimmunotherapy for the treatment of metastatic melanoma. Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 4 Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Tamoxifen; Treatment Outcome	1997
A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma. Melanoma research, 1997, Volume: 7, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Humans; Interferon alpha-2; Interferon-alpha; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Tamoxifen	1997
Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma. Melanoma research, 1998, Volume: 8, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dacarbazine; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Survival Rate; Tamoxifen	1998
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a. British journal of cancer, 1998, Volume: 78, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Risk; Survival Analysis; Tamoxifen; Treatment Outcome	1998
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases. Melanoma research, 1998, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Melanoma, Amelanotic; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Time Factors; Treatment Outcome; Vinblastine	1998
Long-term outcome of treatment with dacarbazine, cisplatin, interferon-alpha and intravenous high dose interleukin-2 in poor risk melanoma patients. Melanoma research, 1998, Volume: 8, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dacarbazine; Humans; Interferon-alpha; Interleukin-2; L-Lactate Dehydrogenase; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Risk; Skin Neoplasms; Survival Rate; Time Factors; Treatment Outcome	1998
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recombinant Proteins; Remission Induction; Tamoxifen	1999
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biological Availability; Consumer Product Safety; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Melanoma; Neoplasm Metastasis; Quality of Life; Regression Analysis; Survival Rate	2000
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma. Melanoma research, 2000, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Lymphopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Safety; Survival Analysis; Thymalfasin; Thymosin; Treatment Outcome	2000
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Recombinant Proteins; Recurrence; Time Factors; Treatment Outcome; Vinblastine	2000
[Treatment of metastatic malignant melanoma (author's transl)]. Wiener klinische Wochenschrift, 1978, Dec-22, Volume: 90, Issue:24 Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Triazenes; Vincristine	1978
Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy. Cancer treatment reports, 1979, Volume: 63, Issue:1 Topics: Adult; Aged; Bleomycin; Clinical Trials as Topic; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Vincristine	1979
Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma. The Australian and New Zealand journal of surgery, 1978, Volume: 48, Issue:3 Topics: Bacterial Vaccines; Colonic Neoplasms; Corynebacterium; Dacarbazine; Female; Fluorouracil; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Triazenes	1978
Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU. Cancer treatment reports, 1977, Volume: 61, Issue:5 Topics: Adult; Aged; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Semustine; Triazenes; Vincristine	1977
Chemotherapy of advanced soft-tissue sarcomas in adults. Cancer treatment reviews, 1977, Volume: 4, Issue:2 Topics: Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Methotrexate; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine	1977
Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer, 1977, Volume: 40, Issue:3 Topics: Brain Neoplasms; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Male; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Prognosis; Remission, Spontaneous; Semustine; Thrombocytopenia; Time Factors; Triazenes	1977
Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination. Cancer, 1978, Volume: 41, Issue:2 Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Procarbazine; Remission, Spontaneous; Time Factors; Triazenes; Vinblastine	1978
Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study. Cancer treatment reports, 1978, Volume: 62, Issue:7 Topics: BCG Vaccine; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Evaluation Studies as Topic; Humans; Immunotherapy; Melanoma; Mycobacterium bovis; Neoplasm Metastasis; Prospective Studies; Triazenes	1978
Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma. Cancer treatment reports, 1978, Volume: 62, Issue:8 Topics: Adult; Aged; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Triazenes	1978
Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study. Cancer treatment reports, 1979, Volume: 63, Issue:3 Topics: Adolescent; Adult; Aged; Child; Cisplatin; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Triazenes	1979
E.O.R.T.C. protocol for the therapy of metastatic soft tissue sarcoma, a randomized trial. European journal of cancer, 1977, Volume: 13, Issue:7 Topics: Adolescent; Adult; Aged; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Research Design; Sarcoma; Soft Tissue Neoplasms; Vincristine	1977
Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma. Surgery, 1978, Volume: 83, Issue:6 Topics: Adult; Aged; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Risk; Skin Neoplasms; Triazenes	1978
DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer treatment reports, 1976, Volume: 60, Issue:2 Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Mice; Neoplasm Metastasis; Nitrosourea Compounds; Remission, Spontaneous; Triazenes	1976
DTIC (NSC-45388) studies in the southwest oncology group. Cancer treatment reports, 1976, Volume: 60, Issue:2 Topics: Carmustine; Chlorpromazine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Melanoma; Nausea; Neoplasm Metastasis; Remission, Spontaneous; Thrombocytopenia; Triazenes; Vincristine; Vomiting	1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer treatment reports, 1976, Volume: 60, Issue:2 Topics: Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Leiomyosarcoma; Neoplasm Metastasis; Sarcoma; Triazenes; Vincristine	1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Clinical pharmacology and therapeutics, 1976, Volume: 19, Issue:6 Topics: Adult; Aged; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Semustine; Triazenes	1976
Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma. Cancer treatment reports, 1976, Volume: 60, Issue:5 Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Neoplasm Metastasis; Pennsylvania; Prospective Studies; Triazenes; Vincristine	1976
Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. Cancer treatment reports, 1976, Volume: 60, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carmustine; Central Nervous System Diseases; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Vincristine	1976
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. The New England journal of medicine, 1992, Aug-20, Volume: 327, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Dacarbazine; Female; Humans; Male; Melanoma; Menopause; Middle Aged; Neoplasm Metastasis; Prospective Studies; Sex Factors; Survival Rate; Tamoxifen	1992
Disseminated melanoma--is there a new standard therapy? The New England journal of medicine, 1992, Aug-20, Volume: 327, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Tamoxifen	1992
High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. Journal of the National Cancer Institute, 1990, Dec-19, Volume: 82, Issue:24 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Sex Factors	1990
Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Vindesine	1989
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Statistics as Topic	1987
Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma. Investigational new drugs, 1988, Volume: 6, Issue:1 Topics: Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis	1988
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Patient Compliance; Random Allocation; Sarcoma; Soft Tissue Neoplasms	1987
Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanoma. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dactinomycin; Humans; Melanoma; Neoplasm Metastasis; Propionibacterium acnes; Prospective Studies; Random Allocation	1986
Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine	1985
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report. Cancer, 1985, Feb-15, Volume: 55, Issue:4 Topics: Adult; Aged; BCG Vaccine; Combined Modality Therapy; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Random Allocation; Skin Neoplasms	1985

Other Studies

192 other study(ies) available for dacarbazine and Metastase

Article	Year
Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells. Pigment cell & melanoma research, 2017, Volume: 30, Issue:5 Topics: B7 Antigens; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Everolimus; Gene Knockdown Techniques; Glycolysis; Humans; Indoles; Melanoma; Molecular Targeted Therapy; Mutation; Neoplasm Metastasis; Protein Kinase Inhibitors; Sulfonamides; Vemurafenib	2017
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide. The American journal of the medical sciences, 2017, Volume: 353, Issue:6 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome	2017
Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy. Pediatric blood & cancer, 2018, Volume: 65, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child, Preschool; Cyclophosphamide; Dacarbazine; Dactinomycin; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Humans; Irinotecan; Male; MicroRNAs; Neoplasm Metastasis; Promoter Regions, Genetic; Rhabdomyosarcoma, Alveolar; RNA, Neoplasm; Temozolomide; Tumor Suppressor Proteins; Vincristine	2018
Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography. Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dacarbazine; Diagnosis, Differential; Early Detection of Cancer; Humans; Isotope Labeling; Magnets; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Porosity; Silicon Dioxide; Technetium; Tomography, Emission-Computed, Single-Photon	2018
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy. Expert opinion on biological therapy, 2018, Volume: 18, Issue:sup1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Clinical Trials, Phase II as Topic; CTLA-4 Antigen; Dacarbazine; Drug Synergism; Female; Follow-Up Studies; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Skin Neoplasms; Survival Analysis; Thymalfasin; Time Factors; Young Adult	2018
Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials. JAMA oncology, 2018, 10-01, Volume: 4, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Dacarbazine; Female; Humans; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Mutation; Neoplasm Metastasis; Piperidines; Prognosis; Proto-Oncogene Proteins B-raf; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vemurafenib	2018
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report. Medicine, 2019, Volume: 98, Issue:25 Topics: Adult; Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Jaw Neoplasms; Lung Neoplasms; Mesna; Neoplasm Metastasis; Neoplasm Recurrence, Local; Treatment Outcome	2019
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma. Clinical & experimental metastasis, 2013, Volume: 30, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; Female; GTP Phosphohydrolases; Humans; Male; Melanoma; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Prognosis; Proto-Oncogene Proteins B-raf; RNA, Messenger	2013
Melanoma of unknown primary origin presenting as a rapidly enlarging adrenal mass. BMJ case reports, 2013, Jun-19, Volume: 2013 Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Diagnosis, Differential; Female; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Unknown Primary; Radiosurgery; Temozolomide; Tomography, X-Ray Computed	2013
Selumetinib shows promise in metastatic uveal melanoma. Cancer discovery, 2013, Volume: 3, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Clinical Trials, Phase II as Topic; Dacarbazine; Disease-Free Survival; Eye Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Temozolomide; Uveal Neoplasms	2013
Effect of temozolomide in patients with metastatic bronchial carcinoids. Neuroendocrinology, 2013, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bronchial Neoplasms; Carcinoid Tumor; Cohort Studies; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Temozolomide; Young Adult	2013
A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy. JOP : Journal of the pancreas, 2013, Sep-10, Volume: 14, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Neutropenia; Pancreatic Neoplasms; Remission Induction; Retrospective Studies; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome	2013
Polish natural bee honeys are anti-proliferative and anti-metastatic agents in human glioblastoma multiforme U87MG cell line. PloS one, 2014, Volume: 9, Issue:3 Topics: Animals; Antineoplastic Agents; Bees; Biological Products; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Glioblastoma; Honey; Humans; Neoplasm Metastasis; Temozolomide	2014
Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:4 Topics: Aged; Antineoplastic Agents; Brain; Brain Neoplasms; Dacarbazine; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies; Temozolomide; Treatment Outcome	2014
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. International journal of cancer, 2014, Dec-01, Volume: 135, Issue:11 Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Polymerase Chain Reaction; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Succinate Dehydrogenase; Survival Rate; Temozolomide; Tumor Suppressor Proteins	2014
Melanoma: you can have your cake and eat it! Nature reviews. Clinical oncology, 2014, Volume: 11, Issue:6 Topics: Antineoplastic Agents; Dacarbazine; Humans; Imidazoles; Melanoma; Neoplasm Metastasis; Oximes; Quality of Life	2014
Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients. PloS one, 2014, Volume: 9, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Dacarbazine; Female; Flow Cytometry; Gene Expression; Humans; Killer Cells, Natural; Leukocyte Count; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; T-Lymphocytes, Regulatory; Transcription Factors; Treatment Outcome	2014
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. Melanoma research, 2014, Volume: 24, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cell Proliferation; Dacarbazine; Female; Humans; Incidence; Indoles; Ipilimumab; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Melanoma; Mutation; Neoplasm Metastasis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib	2014
Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain. Proceedings of the National Academy of Sciences of the United States of America, 2014, Nov-11, Volume: 111, Issue:45 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Capsules; Caspase 3; Dacarbazine; Doxorubicin; Female; Humans; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Proteins; Rats; Rats, Inbred F344; Temozolomide	2014
Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Veterinary and comparative oncology, 2017, Volume: 15, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Cyclophosphamide; Dacarbazine; Dog Diseases; Dogs; Doxorubicin; Female; Hemangiosarcoma; Male; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome	2017
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. The Journal of investigative dermatology, 2015, Volume: 135, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cannabidiol; Cannabinoids; Cannabinol; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dronabinol; Drug Combinations; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plant Extracts; Proto-Oncogene Proteins B-raf; ras Proteins; Skin Neoplasms; Temozolomide	2015
When Hodgkin comes to a head: Hodgkin central nervous system involvement. The American journal of the medical sciences, 2015, Volume: 349, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Vinblastine	2015
Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma. Molecular cancer research : MCR, 2015, Volume: 13, Issue:4 Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Molecular Targeted Therapy; Neoplasm Metastasis; Nodal Protein; Skin Neoplasms	2015
Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression. The Journal of investigative dermatology, 2016, Volume: 136, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Humans; Lomustine; Lung Neoplasms; Macrophage Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Sepsis; Skin Neoplasms; Treatment Outcome; Vincristine	2016
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma. Journal of translational medicine, 2016, 05-03, Volume: 14, Issue:1 Topics: Administration, Metronomic; Animals; Carcinoma, Neuroendocrine; Cell Differentiation; Dacarbazine; Female; Humans; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Temozolomide; Tomography, X-Ray Computed	2016
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors. The oncologist, 2016, Volume: 21, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Disease-Free Survival; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Temozolomide	2016
In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine. Melanoma research, 2016, Volume: 26, Issue:6 Topics: Animals; Celecoxib; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dacarbazine; Disease Models, Animal; Female; Humans; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Skin Neoplasms	2016
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids. Cancer gene therapy, 2016, Volume: 23, Issue:10 Topics: Benzimidazoles; Biomarkers, Tumor; Carcinoid Tumor; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Humans; Neoplasm Metastasis; Phenotype; Poly(ADP-ribose) Polymerase Inhibitors	2016
A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells. Journal of photochemistry and photobiology. B, Biology, 2017, Volume: 166 Topics: Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Perylene; Photochemotherapy; Skin Neoplasms	2017
Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. Leukemia & lymphoma, 2017, Volume: 58, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Vinblastine	2017
Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States. The Journal of dermatological treatment, 2017, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dacarbazine; Databases, Factual; Female; Humans; Indoles; Insurance Claim Review; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms; Sulfonamides; Temozolomide; United States; Vemurafenib; Young Adult	2017
Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas. Hormones & cancer, 2017, Volume: 8, Issue:2 Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Young Adult	2017
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide. Pediatric blood & cancer, 2008, Volume: 51, Issue:4 Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Combined Modality Therapy; Dacarbazine; Female; Humans; Myelodysplastic Syndromes; Neoplasm Metastasis; Neuroblastoma; Recurrence; Temozolomide	2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma. Oncology reports, 2008, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Treatment Outcome	2008
Genomic and molecular profiling predicts response to temozolomide in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2 Topics: Antineoplastic Agents, Alkylating; Area Under Curve; Cell Line, Tumor; Dacarbazine; DNA Methylation; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Humans; Inhibitory Concentration 50; Melanoma; Microsatellite Repeats; Neoplasm Metastasis; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide	2009
The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment. Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:9B Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cardenolides; Cell Line, Tumor; Dacarbazine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Mice, Nude; Microscopy, Video; Neoplasm Metastasis; Neoplasm Transplantation; Sodium-Potassium-Exchanging ATPase; Temozolomide	2009
Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-01, Volume: 15, Issue:7 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Combined Modality Therapy; Dacarbazine; Female; Humans; Melanins; Melanoma; Mice; Mice, Nude; Neoplasm Metastasis; Organometallic Compounds; Positron-Emission Tomography; Radioimmunotherapy; Skin Neoplasms	2009
Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:8 Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Survival Rate; Vincristine	2009
Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide. Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2 Topics: Antineoplastic Agents, Alkylating; Arachnoid; Brain; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; DNA Mutational Analysis; Gene Deletion; Genetic Predisposition to Disease; Genotype; Humans; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Meningeal Neoplasms; Middle Aged; Mutation; Neoplasm Metastasis; Oligodendroglioma; Pia Mater; Radiotherapy; Spinal Cord; Subarachnoid Space; Temozolomide; Treatment Outcome	2009
ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; DNA Damage; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Temozolomide; Tumor Suppressor Proteins	2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma. Melanoma research, 2010, Volume: 20, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Docetaxel; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Skin Neoplasms; Taxoids; Temozolomide; Treatment Outcome	2010
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Dacarbazine; Female; Gene Expression Profiling; Humans; In Situ Hybridization, Fluorescence; Male; Melanoma; Mice; Mice, SCID; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Oligonucleotide Array Sequence Analysis; Organophosphorus Compounds; Polymorphism, Single Nucleotide; Temozolomide; Tumor Cells, Cultured; Uveal Neoplasms; Xenograft Model Antitumor Assays	2010
Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Molecular cancer therapeutics, 2010, Volume: 9, Issue:4 Topics: Aged; Aged, 80 and over; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Regression Analysis; Signal Transduction; Temozolomide; Transcription, Genetic	2010
MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Eye Neoplasms; Female; Humans; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Skin Neoplasms; Tumor Suppressor Proteins	2010
Melanoma metastatic to multiple visceral organs: further considerations. Oncology (Williston Park, N.Y.), 2010, Volume: 24, Issue:7 Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Dose Fractionation, Radiation; Humans; Melanoma; Neoplasm Metastasis; Nose Neoplasms; Palliative Care; Prognosis	2010
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer, 2011, Jan-15, Volume: 117, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Islet Cell; Dacarbazine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Temozolomide; Tomography, X-Ray Computed	2011
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. Clinical colorectal cancer, 2010, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome	2010
Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma. Cancer biology & therapy, 2010, Dec-01, Volume: 10, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Interleukin-2; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Skin Neoplasms; Temozolomide; Treatment Outcome	2010
High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study. Journal of translational medicine, 2010, Nov-10, Volume: 8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide	2010
Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine. Molecular cancer therapeutics, 2010, Volume: 9, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Humans; Melanoma; Mice; Neoplasm Metastasis; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-raf; Retinoblastoma Protein; Thiourea; Xenograft Model Antitumor Assays	2010
Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy. PloS one, 2011, Feb-14, Volume: 6, Issue:2 Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mice; Neoplasm Metastasis; Pheochromocytoma; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Serine; Temozolomide; Threonine	2011
Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia. Melanoma research, 2011, Volume: 21, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Asia; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Young Adult	2011
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer, 2011, Nov-01, Volume: 117, Issue:21 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Female; Hemangiopericytoma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Solitary Fibrous Tumors; Temozolomide; Treatment Outcome	2011
Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2011, Volume: 27, Issue:3 Topics: Animals; Antineoplastic Agents; Cisplatin; Dacarbazine; Female; Fever; Hyperthermia, Induced; Immunity; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis	2011
Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. The Journal of biological chemistry, 2011, Aug-12, Volume: 286, Issue:32 Topics: Acid Ceramidase; Antineoplastic Agents, Alkylating; Autophagy; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Neoplasm Metastasis	2011
Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide. Anticancer research, 2011, Volume: 31, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radiotherapy; Retrospective Studies; Temozolomide; Time Factors	2011
Targeting neuroendocrine tumor: mixing standard options with novel therapies. Targeted oncology, 2012, Volume: 7, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Humans; Indoles; Medical Oncology; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sunitinib; Temozolomide; Treatment Outcome	2012
Multikinase inhibitors in thyroid cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10 Topics: Adenocarcinoma, Follicular; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Clinical Trials as Topic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Iodine Isotopes; Molecular Targeted Therapy; Multiple Endocrine Neoplasia Type 2a; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms	2012
A female with a leiomyosarcoma presenting with acute thoracic pain and dyspnoea. The Netherlands journal of medicine, 2012, Volume: 70, Issue:8 Topics: Chest Pain; Dacarbazine; Dyspnea; Fatal Outcome; Female; Humans; Leiomyosarcoma; Middle Aged; Morphine; Neoplasm Metastasis; Pneumothorax; Radiography, Thoracic; Uterine Neoplasms	2012
Clinical results using biochemotherapy as a standard of care in advanced melanoma. Melanoma research, 2002, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cost-Benefit Analysis; Dacarbazine; Drug Costs; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Interleukin-2; Life Tables; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Failure; Vinblastine	2002
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer immunology, immunotherapy : CII, 2002, Volume: 51, Issue:8 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Immunotherapy; Irritants; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Ribonucleases; RNA, Messenger; T-Lymphocytes; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. Cancer letters, 2002, Dec-05, Volume: 186, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Humans; Immunophenotyping; Inhibitory Concentration 50; Interferon alpha-2; Interferon-alpha; Melanoma; Microscopy, Electron; Neoplasm Metastasis; Paclitaxel; Recombinant Proteins; Temozolomide; Time Factors; Tumor Cells, Cultured; Vindesine	2002
[Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2002, Volume: 53, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Skin Neoplasms; Temozolomide; Time Factors	2002
Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma. British journal of cancer, 2003, Jan-13, Volume: 88, Issue:1 Topics: Animals; Antineoplastic Agents; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Peptides, Cyclic; Somatostatin; Xenograft Model Antitumor Assays	2003
Angiomatoid metastatic melanoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:2 Pt 2 Topics: Antineoplastic Agents; Cancer Vaccines; Combined Modality Therapy; Dacarbazine; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Surgical Procedures, Operative; Treatment Outcome	2004
Metastatic malignant melanoma presenting as a cavernous sinus syndrome. Journal of neurology, 2004, Volume: 251, Issue:2 Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Blepharoptosis; Cavernous Sinus Thrombosis; Cranial Nerves; Dacarbazine; Fatal Outcome; Headache; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Melanoma; Neoplasm Metastasis; Ophthalmoplegia; Orbital Neoplasms; Risk Factors; Skin Neoplasms; Survival Rate; Temozolomide	2004
Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Fatal Outcome; Female; Follow-Up Studies; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Time Factors; Uveal Neoplasms	2005
Lack of response of a metastatic renal perivascular epithelial cell tumor (PEComa) to successive courses of DTIC based-therapy and imatinib mesylate. Pediatric blood & cancer, 2005, Volume: 45, Issue:2 Topics: Angiomyolipoma; Antineoplastic Agents; Benzamides; Child; Dacarbazine; Epithelioid Cells; Fatal Outcome; Female; Humans; Imatinib Mesylate; Kidney Neoplasms; Neoplasm Metastasis; Piperazines; Pyrimidines; Treatment Failure	2005
[Malignant melanoma of nasal fossae: clinical and therapeutic considerations about three cases]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2005, Volume: 9, Issue:2 Topics: Aged; Antineoplastic Agents, Alkylating; Biopsy; Combined Modality Therapy; Dacarbazine; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nasal Mucosa; Nasal Septum; Neoplasm Metastasis; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Time Factors; Turbinates	2005
Alveolar soft part sarcoma: a rare and enigmatic entity. Clinical orthopaedics and related research, 2005, Volume: 438 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Survival Rate	2005
A retrospective study of biochemotherapy for metastatic melanoma: the importance of dose intensity. Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Retrospective Studies; Temozolomide; Treatment Outcome; Vinblastine	2005
Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:2 Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Child; Dacarbazine; Female; Humans; Injections, Intravenous; Irinotecan; Male; Neoplasm Metastasis; Sarcoma, Ewing; Temozolomide	2007
[Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma]. Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Cross-Sectional Studies; Dacarbazine; Drug Hypersensitivity; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms; Time Factors	2006
The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice. Molecular cancer therapeutics, 2006, Volume: 5, Issue:7 Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma; Colonic Neoplasms; Dacarbazine; Glioblastoma; Humans; Irinotecan; Mice; Mice, Nude; Neoplasm Metastasis; Receptors, Vascular Endothelial Growth Factor; Temozolomide; Xenograft Model Antitumor Assays	2006
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. Journal of cancer research and clinical oncology, 2007, Volume: 133, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dinitrochlorobenzene; Disease-Free Survival; Female; Germany; Humans; Irritants; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Analysis	2007
The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas. Investigational new drugs, 2008, Volume: 26, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Treatment Outcome	2008
Low grade astrocytoma presenting with visual loss. Journal of neuro-oncology, 2008, Volume: 89, Issue:1 Topics: Adolescent; Antineoplastic Agents, Alkylating; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; ErbB Receptors; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Optic Nerve; Optic Nerve Neoplasms; Papilledema; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Spinal Cord Neoplasms; Subarachnoid Space; Temozolomide; Thalamus; Vision, Low	2008
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain pathology (Zurich, Switzerland), 2009, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Genes, myc; Glioma; Humans; In Situ Hybridization, Fluorescence; Medulloblastoma; Neoplasm Metastasis; Neoplasms, Multiple Primary; Neuroectodermal Tumors, Primitive; Prognosis; Proto-Oncogene Proteins; Radiotherapy; Temozolomide; Treatment Outcome; Young Adult	2009
Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 106, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Contraindications; Dacarbazine; Female; Humans; Immunotherapy; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Nimustine; Picibanil; Prognosis; Risk Factors; Tooth Extraction; Vincristine	2008
[Neuroblastoma study NBL79-society of pediatric oncology -- report after 1 year (author's transl)]. Klinische Padiatrie, 1981, Volume: 193, Issue:3 Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Infant; Interferons; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Vincristine	1981
Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma. Cancer treatment reports, 1983, Volume: 67, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Female; Humans; Male; Melanoma; Neoplasm Metastasis; Vincristine	1983
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma. Cancer treatment reports, 1984, Volume: 68, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Mitolactol; Neoplasm Metastasis; Vinblastine	1984
Therapy of malignant APUD cell tumors. Effectiveness of DTIC. Cancer, 1983, Mar-01, Volume: 51, Issue:5 Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Dacarbazine; Female; Humans; Ileal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Thyroid Neoplasms	1983
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. International journal of tissue reactions, 1984, Volume: 6, Issue:6 Topics: Aged; B-Lymphocytes; Dacarbazine; Female; Humans; Leukocyte Count; Lomustine; Lymphocytes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; T-Lymphocytes	1984
Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:7 Topics: Animals; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Tests; Cyclophosphamide; Dacarbazine; Female; Fibrinogen; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Piperazines; Platelet Aggregation; Platelet Count; Razoxane; Triazenes	1984
Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer treatment reports, 1984, Volume: 68, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
Efficacy of chemotherapeutic treatment of guinea pig hepatoma reflected in host's serum lipid composition. Journal of the National Cancer Institute, 1983, Volume: 70, Issue:4 Topics: Animals; Clinical Laboratory Techniques; Dacarbazine; Doxorubicin; Guinea Pigs; Lipids; Liver Neoplasms, Experimental; Male; Neoplasm Metastasis; Prognosis	1983
[Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Nimustine; Nitrosourea Compounds; Picibanil; Vincristine	1984
Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course. Clinical immunology and immunopathology, 1983, Volume: 28, Issue:3 Topics: Adult; Aged; B-Lymphocytes; Dacarbazine; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Rosette Formation; Skin Neoplasms; T-Lymphocytes; Thymus Extracts	1983
[Chemotherapy of malignant soft tissue tumors]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1983, Volume: 54, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Neoplasm Metastasis; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine	1983
Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1981, Volume: 79 Topics: Adenocarcinoma; Colonic Neoplasms; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Radionuclide Imaging; Time Factors	1981
[DTIC, CTX, ADM and VCT in children with metastatic neuroblastoma]. Minerva pediatrica, 1983, Feb-28, Volume: 35, Issue:4 Topics: Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Vincristine	1983
Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. Cancer treatment reports, 1983, Volume: 67, Issue:6 Topics: Adult; Aged; Carcinoid Tumor; Dacarbazine; Dactinomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies	1983
Combination of modalities in soft tissue sarcomas. International advances in surgical oncology, 1982, Volume: 5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine	1982
Phase II study of cyclophosphamide, vincristine and D.T.I.C. +/- B.C.G. in the treatment of malignant melanoma. Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aged; BCG Vaccine; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Vincristine	1982
[Results of cytostatic therapy with cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) in localized and metastasized osteosarcoma. A retrospective analysis]. Onkologie, 1980, Volume: 3, Issue:2 Topics: Adolescent; Adult; Bone Neoplasms; Child; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Femoral Neoplasms; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Tibia; Vincristine	1980
Combined effects of natural resistance and chemotherapy against a murine lymphoma in lethally-irradiated mice. International journal of cancer, 1981, Oct-15, Volume: 28, Issue:4 Topics: Animals; Cyclophosphamide; Dacarbazine; Hybridization, Genetic; Immunity, Innate; Liver; Lung; Lymphoma; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Spleen; Whole-Body Irradiation	1981
A five-drug combination in the treatment of metastatic breast cancer. Cancer clinical trials, 1981, Volume: 4, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone	1981
Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan. Cancer, 1980, May-15, Volume: 45, Issue:10 Topics: Adult; Aged; BCG Vaccine; Blood Cell Count; Dacarbazine; Drug Therapy, Combination; Female; Humans; Immunocompetence; Immunotherapy; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Prognosis; Skin Tests; Time Factors; Transfer Factor	1980
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer treatment reports, 1980, Volume: 64, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Leukopenia; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine	1980
[Photosensitization with DTIC therapy in metastatic malignant melanoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1980, Volume: 31, Issue:11 Topics: Aged; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Photosensitivity Disorders; Skin Neoplasms	1980
[Anorectal malignant melanomas. Apropos of 5 cases. Review of the literature]. Annales de gastroenterologie et d'hepatologie, 1995, Volume: 31, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Vindesine	1995
Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma. Clinical & experimental metastasis, 1995, Volume: 13, Issue:2 Topics: Animals; Carcinoma, Lewis Lung; Dacarbazine; Female; Mice; Mice, Inbred C57BL; Neoplasm Metastasis	1995
Combination chemotherapy of metastatic melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Tamoxifen	1995
Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin. Cancer treatment and research, 1993, Volume: 62 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Dacarbazine; Dactinomycin; Evaluation Studies as Topic; Extremities; Humans; Hyperthermia, Induced; Incidence; Melanoma; Melphalan; Neoplasm Metastasis; Osteosarcoma; Rhabdomyolysis; Skin Neoplasms; Treatment Outcome	1993
Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer research, 1993, Oct-15, Volume: 53, Issue:20 Topics: Antibodies, Monoclonal; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molecules; Dacarbazine; Humans; Immunoenzyme Techniques; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interferon-beta; Liver Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Skin Neoplasms; Vincristine	1993
Outcome and prognostic factors in soft tissue sarcoma in the adult. International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Time Factors; Treatment Outcome; Vincristine	1993
[Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma]. Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:6-7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Interferon-alpha; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Treatment Outcome	1993
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-CD8 Ratio; Dacarbazine; Female; Humans; Immunotherapy; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Survival Analysis; Vincristine	1996
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL). Cancer immunology, immunotherapy : CII, 1995, Volume: 41, Issue:6 Topics: Animals; Antigens, CD; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Dacarbazine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Immunologic Factors; Integrin alpha6; Interleukin-2; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; T-Lymphocytes, Cytotoxic	1995
Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma? Melanoma research, 1996, Volume: 6, Issue:3 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Female; Humans; Interferons; Lomustine; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Sex Characteristics; Subrenal Capsule Assay; Vincristine	1996
Suppression of metastatic potential and up-regulation of gelatinases and uPA in LLC by protracted in vivo treatment with dacarbazine or razoxane. International journal of cancer, 1997, Sep-17, Volume: 72, Issue:6 Topics: Animals; Collagenases; Dacarbazine; Gelatinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Immunosuppression Therapy; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Razoxane; RNA, Messenger; Transcription, Genetic; Urokinase-Type Plasminogen Activator	1997
Immunochemotherapy with recombinant interferon-alpha 2b plus dacarbazine in the treatment of advanced malignant melanoma. Melanoma research, 1997, Volume: 7, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recombinant Proteins; Skin Neoplasms; Soft Tissue Neoplasms; Survival Rate; Time Factors	1997
[Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma]. Annales de dermatologie et de venereologie, 1996, Volume: 123, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Treatment Outcome	1996
Management of cerebral metastases from malignant melanoma: results of a combined, simultaneous treatment with fotemustine and irradiation. Journal of neuro-oncology, 1999, Volume: 43, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Analysis	1999
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Journal of experimental & clinical cancer research : CR, 2000, Volume: 19, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Tamoxifen; Treatment Outcome	2000
MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:4 Topics: Animals; Benzoquinones; Colonic Neoplasms; Colorectal Neoplasms; Dacarbazine; Humans; Lectins; Liver Neoplasms; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Metastasis; Plant Extracts; Transplantation, Heterologous	1999
What can we learn from phase II adjuvant trials in melanoma? British journal of cancer, 2000, Volume: 83, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Controlled Clinical Trials as Topic; Dacarbazine; Drug Synergism; Humans; Immunologic Factors; Interferons; Interleukin-2; Melanoma; Neoplasm Metastasis; Randomized Controlled Trials as Topic; Research Design; Skin Neoplasms; Tamoxifen; Treatment Outcome; Vinblastine	2000
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model. Melanoma research, 2001, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Dose-Response Relationship, Drug; Female; Immunotherapy; Irritants; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Time Factors	2001
Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients. Melanoma research, 2001, Volume: 11, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Survival Analysis	2001
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma. Cancer treatment reports, 1976, Volume: 60, Issue:9 Topics: Adult; Aged; Ancitabine; Brain Neoplasms; Cytarabine; Dacarbazine; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasm Metastasis; Retroperitoneal Neoplasms; Skin Neoplasms; Triazenes	1976
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma. Medical and pediatric oncology, 1978, Volume: 4, Issue:1 Topics: Azacitidine; Bone Marrow; Dacarbazine; Drug Evaluation; Drug Resistance; Female; Humans; Injections, Subcutaneous; Male; Melanoma; Neoplasm Metastasis; Vomiting	1978
Concept of cytostatic therapy in advanced tumours of the head and neck. Journal of maxillofacial surgery, 1979, Volume: 7, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Catheterization; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Injections, Intravenous; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Vincristine	1979
Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma. Tumori, 1979, Apr-30, Volume: 65, Issue:2 Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Metastasis; Vinblastine	1979
Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1978, Volume: 68 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bacterial Vaccines; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Propionibacterium acnes; Streptonigrin; Thiotepa; Vinblastine	1978
Chemotherapy in the treatment of malignant melanomas. Transactions of the ophthalmological societies of the United Kingdom, 1977, Volume: 97, Issue:3 Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Drug Therapy, Combination; Humans; Injections, Intra-Arterial; Melanoma; Neoplasm Metastasis	1977
[T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma]. Zeitschrift fur Hautkrankheiten, 1978, Feb-01, Volume: 53, Issue:3 Topics: Adolescent; Adult; Aged; BCG Vaccine; Cell Count; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; T-Lymphocytes	1978
Chemotherapy for sarcoma of the stomach. Cancer treatment reports, 1979, Volume: 63, Issue:3 Topics: Adult; Aged; Asparaginase; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Semustine; Stomach Neoplasms; Vincristine	1979
Recurrent orbital and metastatic melanoma in a patient undergoing previous glaucoma surgery. American journal of ophthalmology, 1979, Volume: 87, Issue:6 Topics: Choroid Neoplasms; Dacarbazine; Female; Glaucoma; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Orbital Neoplasms	1979
[Combined chemotherapy and radiotherapy of localized and metastasizing Ewing's sarcoma (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1979, Jun-01, Volume: 104, Issue:22 Topics: Adolescent; Adult; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine	1979
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. British journal of cancer, 1977, Volume: 36, Issue:6 Topics: Adult; Aged; BCG Vaccine; Cytotoxicity, Immunologic; Dacarbazine; Female; Humans; Leukocyte Count; Lymphocytes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Rosette Formation	1977
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas. Medical and pediatric oncology, 1978, Volume: 4, Issue:1 Topics: Adult; Antineoplastic Agents; BCG Vaccine; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methanol; Neoplasm Metastasis; Remission, Spontaneous; Sarcoma	1978
Neuroblastoma in the adult: effective combination chemotherapy. Cancer, 1978, Volume: 41, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Neoplasm Metastasis; Neuroblastoma; Remission, Spontaneous; Time Factors; Vincristine	1978
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence. British journal of cancer, 1978, Volume: 37, Issue:4 Topics: Adult; Aged; Antigens, Neoplasm; BCG Vaccine; Dacarbazine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Time Factors; Vincristine	1978
Alveolar soft part sarcoma. Journal of surgical oncology, 1978, Volume: 10, Issue:3 Topics: Adult; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Neoplasm Metastasis; Sarcoma; Shoulder; Soft Tissue Neoplasms	1978
Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice. Cancer treatment reports, 1978, Volume: 62, Issue:5 Topics: Animals; Antineoplastic Agents; Dacarbazine; DNA, Neoplasm; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Triazenes	1978
[Treatment of metastasising soft-tissue sarcoma with a uniform combination chemotherapy of cyclosphosphamide, vincristin, adriamycin and DTIC ("CyVADIC") (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1978, Jul-28, Volume: 103, Issue:30 Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fibrosarcoma; Humans; Male; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine	1978
Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma. Cancer treatment reports, 1978, Volume: 62, Issue:10 Topics: Adult; Aged; Amphotericin B; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Sarcoma; Vincristine	1978
[DTIC in the therapy of solid tumours (author's transl)]. Wiener klinische Wochenschrift, 1978, Dec-22, Volume: 90, Issue:24 Topics: Antineoplastic Agents; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Neoplasms; Otorhinolaryngologic Diseases; Sarcoma, Kaposi; Soft Tissue Neoplasms; Thymoma; Thymus Neoplasms; Triazenes	1978
Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea. Cancer treatment reports, 1978, Volume: 62, Issue:12 Topics: Adult; Aged; Bone Marrow; Dacarbazine; Drug Evaluation; Drug Resistance; Female; Humans; Male; Melanoma; Middle Aged; Mitolactol; Neoplasm Metastasis; Nitrosourea Compounds; Remission, Spontaneous; Triazenes	1978
Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1978, Volume: 68 Topics: Adult; Aged; BCG Vaccine; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Triazenes	1978
Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update. The Journal of dermatologic surgery and oncology, 1979, Volume: 5, Issue:2 Topics: Amphotericin B; BCG Vaccine; Dacarbazine; Drug Combinations; Estradiol Congeners; Female; Hot Temperature; Humans; Melanoma; Methotrexate; Neoplasm Metastasis; Nitrosourea Compounds; Skin Neoplasms	1979
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Cancer treatment reports, 1976, Volume: 60, Issue:2 Topics: BCG Vaccine; Blood Cell Count; Dacarbazine; Drug Therapy, Combination; Humans; Immunotherapy; Lomustine; Melanoma; Mycobacterium bovis; Neoplasm Metastasis; Propionibacterium acnes; Remission, Spontaneous; Triazenes; Vincristine	1976
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma. Cancer, 1977, Volume: 39, Issue:1 Topics: Carmustine; Dacarbazine; Drug Therapy, Combination; Eosinophils; Female; Humans; Leukocyte Count; Lymphocytes; Male; Melanoma; Neoplasm Metastasis; Remission, Spontaneous; Triazenes; Vincristine	1977
Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine. Cancer, 1977, Volume: 39, Issue:1 Topics: Adult; Aged; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Triazenes; Vincristine	1977
Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. Cancer, 1977, Volume: 39, Issue:1 Topics: Carmustine; Chlorpromazine; Dacarbazine; Drug Therapy, Combination; Eosinophils; Female; Humans; Leukocyte Count; Lymphocytes; Male; Melanoma; Monocytes; Neoplasm Metastasis; Remission, Spontaneous; Time Factors; Triazenes; Vincristine	1977
Immunochemotherapy of malignant melanoma with chlorambucil-bound antimelanoma globulins: preliminary results in patients with disseminated disease. Journal of the National Cancer Institute, 1977, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Antibodies, Neoplasm; Chlorambucil; Dacarbazine; Female; Humans; Hypersensitivity, Delayed; Immunoglobulins; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	1977
Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report. Cancer, 1977, Volume: 39, Issue:5 Topics: Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neurilemmoma; Remission, Spontaneous; Time Factors; Triazenes; Vincristine	1977
Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma. Minnesota medicine, 1977, Volume: 60, Issue:8 Topics: Antineoplastic Agents; Carmustine; Dacarbazine; Drug Therapy, Combination; Humans; Hydroxyurea; Lomustine; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Vincristine	1977
Advances in the chemotherapy of soft tissue sarcomas. The Medical clinics of North America, 1977, Volume: 61, Issue:5 Topics: Adult; Antineoplastic Agents; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leiomyosarcoma; Neoplasm Metastasis; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Time Factors; Vincristine	1977
Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy. European journal of cancer, 1977, Volume: 13, Issue:10 Topics: Adult; Antigens, Neoplasm; BCG Vaccine; Dacarbazine; Female; Humans; Immunotherapy; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Skin Neoplasms; Triazenes	1977
Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors. Medical and pediatric oncology, 1976, Volume: 2, Issue:2 Topics: Child; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Neoplasm Metastasis; Neoplasms; Pneumonia; Remission, Spontaneous; Triazenes	1976
Immunotherapy and chemotherapy in children with neuroblastoma. Journal of the National Cancer Institute, 1976, Volume: 57, Issue:3 Topics: Adult; Antineoplastic Agents; BCG Vaccine; Child; Cyclophosphamide; Dacarbazine; Humans; Neoplasm Metastasis; Neuraminidase; Neuroblastoma; Pilot Projects; Remission, Spontaneous; Vibrio cholerae; Vincristine	1976
Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine. Cancer treatment reports, 1976, Volume: 60, Issue:9 Topics: Adult; Aged; Carmustine; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Triazenes; Vincristine	1976
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer. Annals of the New York Academy of Sciences, 1976, Volume: 277, Issue:00 Topics: BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Melanoma; Neoplasm Metastasis; Rectal Neoplasms; Time Factors	1976
Chemotherapy of osteosarcoma [proceedings]. Proceedings of the Royal Society of Medicine, 1976, Volume: 69, Issue:8 Topics: Bone Neoplasms; Child; Dacarbazine; Doxorubicin; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine	1976
Increased incidence of cerebral metastases in sarcoma patients with prolonged survival from chemotherapy. Report of cases of leiomysarcoma and chondrosarcoma. Cancer, 1975, Volume: 36, Issue:5 Topics: Adult; Brain Neoplasms; Chondrosarcoma; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Metastasis	1975
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. Medical and pediatric oncology, 1975, Volume: 1, Issue:2 Topics: Adult; Aged; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Procarbazine; Remission, Spontaneous; Skin Neoplasms; Triazenes; Vincristine	1975
Chemotherapy of melanoma. Seminars in oncology, 1975, Volume: 2, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Semustine; Skin Neoplasms; Vinca Alkaloids	1975
Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Annals of internal medicine, 1976, Volume: 84, Issue:2 Topics: Aged; Dacarbazine; Disseminated Intravascular Coagulation; Humans; Male; Melanoma; Neoplasm Metastasis; Triazenes	1976
[Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1976, Jun-04, Volume: 101, Issue:23 Topics: Adult; Bone Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Skin Neoplasms; Soft Tissue Neoplasms; Triazenes; Vincristine	1976
Fotemustine plus dacarbazine in advanced stage III malignant melanoma. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Thrombocytopenia	1992
Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit. British journal of cancer, 1990, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Vincristine; Vindesine	1990
Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma. Cancer research, 1991, Jun-01, Volume: 51, Issue:11 Topics: Animals; Cyclophosphamide; Dacarbazine; Humans; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Tumor Cells, Cultured	1991
Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide. Onkologie, 1990, Volume: 13, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate	1990
[Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results]. Pathologie-biologie, 1990, Volume: 38, Issue:8 Topics: Antineoplastic Agents; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Humans; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms	1990
[Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma]. Der Internist, 1990, Volume: 31, Issue:1 Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dyspnea; Female; Follow-Up Studies; Humans; Hypertension; Neoplasm Metastasis; Phenoxybenzamine; Pheochromocytoma; Tomography, X-Ray Computed; Vincristine	1990
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma. Cancer, 1990, Jun-01, Volume: 65, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; T-Lymphocytes	1990
Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial. American journal of clinical oncology, 1990, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Humans; Melanoma; Neoplasm Metastasis; Remission Induction; Vindesine	1990
[Therapeutic response of interferon-beta in malignant melanoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Indomethacin; Infusions, Parenteral; Interferon Type I; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Vincristine	1986
[Treatment of metastatic breast cancer]. Harefuah, 1986, Volume: 111, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone; Random Allocation; Vinblastine; Vincristine	1986
Sarcomatoid renal cell carcinoma. A treatable entity. Cancer, 1987, Sep-15, Volume: 60, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Interferons; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Sarcoma; Vincristine	1987
Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma. Cancer, 1988, Jun-01, Volume: 61, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Humans; Lomustine; Melanoma; Neoplasm Metastasis; Vincristine	1988
The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma. Cancer, 1985, May-01, Volume: 55, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine	1985
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. Cancer, 1989, Apr-01, Volume: 63, Issue:7 Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Dacarbazine; Humans; Ifosfamide; Lung Neoplasms; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	1989
[The effect of chemotherapy on survival time in advanced breast carcinoma]. Deutsche medizinische Wochenschrift (1946), 1989, Jun-16, Volume: 114, Issue:24 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Postoperative Care; Prednisone; Retrospective Studies; Time Factors; Vincristine	1989
Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion. Connecticut medicine, 1985, Volume: 49, Issue:12 Topics: Adenoma, Islet Cell; Dacarbazine; Gastrins; Glucagon; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Zollinger-Ellison Syndrome	1985
Role of host responses in the drug treatment of metastasis. Advances in experimental medicine and biology, 1988, Volume: 233 Topics: Animals; Antineoplastic Agents; Dacarbazine; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms; Triazenes	1988
[Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas]. Onkologie, 1987, Volume: 10, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Pleural Neoplasms; Sarcoma; Soft Tissue Neoplasms; Vincristine	1987
Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group. Cancer, 1988, Sep-15, Volume: 62, Issue:6 Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Vindesine	1988
Treatment of metastatic malignant melanoma with dacarbazine and cisplatin. Cancer treatment reports, 1987, Volume: 71, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects	1987
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. Clinical & experimental metastasis, 1987, Volume: 5, Issue:3 Topics: Animals; Dacarbazine; Hemorrhage; Lung Neoplasms; Mice; Neoplasm Metastasis; Piperazines; Razoxane; Triazenes	1987
Treatment of metastatic melanoma by 24-hour DTIC infusions and hemibody irradiation. Cancer, 1986, Jun-01, Volume: 57, Issue:11 Topics: Adult; Aged; Combined Modality Therapy; Dacarbazine; Evaluation Studies as Topic; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radiotherapy Dosage; Skin Neoplasms; Time Factors	1986
Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma. Cancer treatment reports, 1986, Volume: 70, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Vindesine	1986
[Prognosis-oriented therapy of malignant melanoma. New concepts]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1986, Volume: 37, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Lymph Node Excision; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Risk; Skin; Skin Neoplasms	1986
Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma. Journal of biological response modifiers, 1986, Volume: 5, Issue:5 Topics: Adult; Cimetidine; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Interferon Type I; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins	1986
[Chemotherapy of malignant melanoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1986, Volume: 57, Issue:10 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Prognosis; Skin Neoplasms; Tamoxifen	1986
Prognostic factors in advanced metastatic and recurrent melanoma treated with DTIC. Tumori, 1987, Feb-28, Volume: 73, Issue:1 Topics: Dacarbazine; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis	1987
cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvis. Gynecologic oncology, 1986, Volume: 23, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Neoplasm Metastasis; Pelvic Neoplasms; Sarcoma	1986
Single-dose dacarbazine and dactinomycin in advanced malignant melanoma. Cancer treatment reports, 1985, Volume: 69, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dactinomycin; Female; Humans; Leukocyte Count; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Platelet Count; Urinary Tract Infections	1985
Combination of dacarbazine and doxorubicin in the treatment of childhood rhabdomyosarcoma. Cancer treatment reports, 1985, Volume: 69, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Humans; Neoplasm Metastasis; Rhabdomyosarcoma	1985
[Therapy of malignant melanoma]. Deutsche medizinische Wochenschrift (1946), 1985, Nov-15, Volume: 110, Issue:46 Topics: Combined Modality Therapy; Dacarbazine; Humans; Lymphatic Metastasis; Melanoma; Methods; Neoplasm Metastasis	1985